Venice, Italy October 27-29, 2013 13 Edition venice... · venice, italy october 27-29, 2013 13th...
Transcript of Venice, Italy October 27-29, 2013 13 Edition venice... · venice, italy october 27-29, 2013 13th...
PresidentsAntonio RavieleAndrea NataleSakis Themistoclakis
Venice, ItalyOctober 27-29, 2013
13th Edition
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
ceremony
open
ing
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
mainSympoSia/
core cUrricULa
debates
CO
NTRO
VERSIES
featu
red
symposia
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
PRESENTA
TION
S
MAINSYMPOSIA/ CORE CURRICULA
CO
RNERS
AWARDS
LIVE
Venice, October 6 - 9, 2013
2013
SEE YOU AT
VA2011 PRG DEF 1509.indd Sez1:266 16-09-2011 11:52:30
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
2
LECTURES
OPEN
ING
DEBATES
CO
NTR
OV
ERSIES
CEREMONY
SYMPOSIA
FEATU
RED
VA2011 PRG DEF 1509 x abb.indd 2 16-09-2011 12:14:08
Program Chairs
1 Advance Program
Invitation Letter
ear Colleagues,
We are delighted to announce the 13th edition of VeniceArrhythmias that will be held at Fondazione Giorgio Cini in Venice, Italy on October the 27th
through the 29th, 2013.VeniceArrhythmias, a biannual meeting started in 1989 and, year after year, has become one of the most important international congresses in the field of arrhythmology with almost 3000 attendees and with more than 350 invited speakers.
This year, we are keen on further increasing the number of participants by proposing an even more attractive, innovative and focused scientific program that handles all the aspects of cardiac arrhythmias. The main topics of the upcoming edition will be: anatomy of the heart for electrophysiologists, atrial fibrillation from A to Z, AF clinical trials update 2013, anti-thrombotic therapy for cardiac arrhythmias, arrhythmias in the elderly, pediatric aspects of arrhythmias, sport and arrhythmias, hereditary arrhythmogenic syndromes, contemporary and controversial issues in cardiac pacing, syncope, heart failure and cardiac resynchronization therapy, remote monitoring of cardiac arrhythmias/devices, sudden death, ICD and surroundings, new technologies and techniques in catheter ablation, cardiac arrhythmias surgery. The program will be organized in different sessions: from main symposia to debates, lectures, practical sessions, satellite events, oral and poster communications and allied professionals program.
As in the past, one of the main features of Venice Arrhythmias is the precious and valuable cooperation with the main Scientific Societies in the field of cardiac electrophysiology and pacing - like HRS and EHRA- whose representatives will offer their expertise aiming at preparing stimulating and multidisciplinary sessions on the most updated and controversial topics.
Special focus will be given also to the Geographic Area corners prepared directly by leading cardiologists from different countries who will have the chance to express and expose their growing research and competence.
Last but not least, Venice will offer the perfect setting to this workshop and its natural, architectural and historical beauty will create a spectacular stage where to forge new relations and strengthen old friendships.
Our goal is to meet every participant’s needs and we would be more than pleased to have you taking part in an event that is expected to be wonderful and unforgettable.
We look forward to welcoming you in Venice.
Sincerely,
D
Sakis ThemistoclakisMD
Andrea NataleMD, FACC, FESC, FHRS
Antonio RavieleMD, FESC, FHRS
2
Endorsements & Auspices
APHRS Asia Pacific Heart Rhythm Society
CHRSCanadian Heart Rhythm Society
ECASEuropean CardiacArrhythmia Society
CSPEChinese Society of Pacing and Electrophysiology
AIAC Associazione Italianadi Aritmologia e Cardiostimolazione
ANCEAssociazione ItalianaCardiologi Extraospedalieri
GITICGruppo Italiano Infermieri di Cardiologia
SOLAECESociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología
SOBRACSociedade Brasileira de Arritmias Cardíacas
JHRSJapanese Heart Rhythm Society
WSAWorld Society of Arrhythmias
Under the auspices of
FICFederazione Italiana di Cardiologia
IRHRSIranian Heart Rhythm Society
ISHNEInternational Society for Holter & Noninvasive Electrocardiology
SHRSSaudi Heart Rhythm Society
TKDTurkish Society of Cardiology
AAArrhythmia Alliance
AFAAtrial Fibrillation Association
STARSSyncope Trust and Reflex Anoxic Seizures
SACSociedad Argentina de Cardiologia
SMCSociedad Mexicanade Cardiologia
StopAfibStopAfib Association
IHRSIndian Heart Rhythm Society
RSCAAll Russian Scientific Societies of Arrhythmology, Electrophysiology and Pacing
WHFWorld Heart Federation
SADECSociedad Argentina de Electrofisiologia Cardiaca
GIECGruppo per l’Intervento nelle Emergenze Cardiologiche
ARCAAssociazione Regionale Cardiologi Ambulatoriali
SOMEECSociedad Mexicana de Electrofisiología y Estimulación Cardíaca
EHRAEuropean HeartRhythm Association,a Registered Branch of the ESC
HRSHeart RhythmSociety
Endorsed by
Program Chairs
3 Advance Program
Presidents / Congress Venue
ANTONIO RAvIELE
ALliance to FightAtrial fibrillation
- ALFA -Venice-Mestre, Italy
ANDREA NATALE
Texas CardiacArrhythmia Institute
St. David’s Medical CenterAustin, USA
SAKIS THEMISTOCLAKIS
Department of Cardiothoracic& vascular MedicineOspedale dell’AngeloVenice-Mestre Italy
ALliance to Fight Atrial fibrillation
AziendaULSS 12 veneziana
Under the patronage of
Provinceof venice
veneto RegionAziendaULSS 12 veneziana
Municipalityof venice
4
President
Giuseppe Dal Ben, Italy
Members
Vittorio Dorrucci, Italy
Rita Finotto, Italy
Onofrio Lamanna, Italy
Domenico Mangino, Italy
Fausto Rigo, Italy
Organizing Committee
Fondazione Giorgio Cini | Isola San Giorgio Maggiore | Venice - Italy
Congress Venue
Program Chairs
5 Advance Program
Program Committee
Chairmen
Andrea Natale, USA
Members
Pedro Adragão, Portugal
Paolo Alboni, Italy
Etienne Aliot, France Andrey Ardashev, Russia
Angelo Auricchio, Switzerland
Cristina Basso, Italy
David G. Benditt, USA
Jean Jacques Blanc, France
Maria Grazia Bongiorni, Italy
Martin Borggrefe, Germany
Günter Breithardt, Germany
Hugh Calkins, USA
David Callans, USA
John A. Camm, UK
Riccardo Cappato, Italy
Shih Ann Chen, Taiwan
Stuart J. Connolly, Canada
Stefania Damiani, Italy
Ralph J. Jr. Damiano, USA
Luigi Di Biase, USA
Paul Dorian, Canada
Nabil E. El-Sherif, USA
Andrew E. Epstein, USA
Guilherme Fenelon, Brazil
Nestor Galizio, Argentina
Franco Giada, Italy
Anne M. Gillis, Canada
Andreas Goette, Germany
Michael R. Gold, USA
Bulent Gorenek, Turkey
Peter Guerra, Canada
Richard N.W. Hauer, The Netherlands
Joachim Hebe, Germany
Gerhard Hindricks, Germany
Kenzo Hirao, Japan
Siew Yen Ho, UK
Stefan H. Hohnloser, Germany
Sabino Iliceto, Italy
Warren M. Jackman, USA
Charles Jazra, Lebanon
Werner Jung, Germany
Charles Kennergren, Sweden
Maurice Khoury, Lebanon
Young Hoon Kim, Korea
Maria Teresa La Rovere, Italy
Chu-Pak Lau, China
Gregory Y.H. Lip, UK
Trudie Lobban, UK
Domenico Mangino, Italy
Francis E. Marchlinski, USA
Barry J. Maron, USA
Ali Massumi, USA
José L. Merino, Spain
Luís Molina, Mexico
Antonio Raviele, Italy Sakis Themistoclakis, Italy
6
Program Committee
Lluís Mont, Spain
Carlos Morais, Portugal
John M. Morgan, UK
Hiroshi Nakagawa, USA
Yuji Nakazato, Japan
Brian Olshansky, USA
Oscar Oseroff, Argentina
Ali Oto, Turkey
Eli I. Ovsyshcher, Israel
Eric N. Prystowsky, USA
Amiran Revishvili, Russia
Nicolas Reyes, Mexico
Antonio Rossillo, Italy
Eduardo Saad, Brazil
Sanjeev Saksena, USA
Massimo Santini, Italy
Mauricio Scanavacca, Brazil
Melvin M. Scheinman, USA
Kamal K. Sethi, IndiaDipen Shah, SwitzerlandWin-Kuang Shen, USAMohammad Shenasa, USAJonathan S. Steinberg, USAPeter H. Stone, USAMargaret J. Strieper, USASakis Themistoclakis, ItalyBarbara Thomas, USADiego Vanegas, ColombiaPanos E. Vardas, GreeceRodolfo Ventura, GermanyAtul Verma, CanadaSami Viskin, IsraelArthur A. Wilde, The NetherlandsBruce L. Wilkoff, USAJerzy K. Wranicz, PolandWojciech Zareba, USAShu Zhang, China
Program Chairs
7 Advance Program
Faculty
H. Abdul-Khaliq / Homburg Saar, GermanyM.J. Ackerman / Rochester, USAP. Adragão / Carnaxide, PortugalL. Aguinaga / Tucumán, ArgentinaA.M. Al Musaad / Riyadh, Saudi ArabiaA. Al-Ahmad / Palo Alto, USAP. Alboni / Ferrara, ItalyE. Aliot / Vandoeuvre-lès-Nancy, FranceA. Alsheikh-Ali / Abu Dhabi, UEAC. Antona / Milan, ItalyC. Antzelevitch / Utica, USAA. Ardashev / Moscow, RussiaA. Arya / Tehran, IranG. Barbato / Bologna, ItalyA. Bartoletti / Florence, ItalyC. Basso / Padua, ItalyS. Beheiry / San Francisco, USAE. Behr / London, UKD.G. Benditt / Minneapolis, USAS. Benussi / Milan, ItalyE. Bertaglia / Padua, ItalyA. Biffi / Rome, ItalyJ.J. Blanc / Brest, FranceP.E. Bloch-Thomsen / Hellerup, DenmarkN.A. Blom / Leiden, The NetherlandsC. Blomström-Lundqvist / Uppsala, SwedenT. Blum / Bad Krozingen, GermanyL. Boersma / Nieuwegein, The NetherlandsM.G. Bongiorni / Pisa, ItalyH. Bonnemeier / Kiel, GermanyA. Bonso / Feltre, ItalyM. Borggrefe / Mannheim, GermanyG. Boriani / Bologna, ItalyG.L. Botto / Como, ItalyJ. Brachmann / Coburg, GermanyG. Breithardt / Münster, GermanyM. Brignole / Lavagna, Italy
M. Brown / Austin, USAJ.D. Burkhardt / Austin, USAF. Cademartiri / Monastier, ItalyH. Calkins / Baltimore, USAD. Callans / Philadelphia, USAL. Calò / Rome, ItalyA.J. Camm / London, UKD.S. Cannom / Los Angeles, USAR. Cappato / San Donato Milanese, ItalyL. Cappellesso / Venice-Mestre, ItalyA. Capucci / Ancona, ItalyC. Carbucicchio / Milan, ItalyP. Carmo / Carnaxide, PortugalM. Casella / Milan, ItalyD. Cavaco / Carnaxide, PortugalF. Cecchi / Florence, ItalyT.F. Chao / Taipei, TaiwanS.A. Chen / Taipei, TaiwanJ.B. Chierchia / Brussels, BelgiumP. China / Venice-Mestre, ItalyJ. Clark / Akron, USAR. Codecasa / Florence, ItalyS.J. Connolly / Hamilton, CanadaJ. Copeland / Akron, USAD. Corrado / Padua, ItalyL. Couts / San Diego, USAC. Cronin / Austin, USAA. Curnis / Brescia, ItalyA. D’Avila / New York, USAS. Damiani / Venice-Mestre, ItalyR.J. Jr. Damiano / St. Louis, USAJ.C. Daubert / Rennes, FranceR. De Caterina / Chieti, ItalyA. De Conto / Conegliano Veneto, ItalyR. De Ponti / Varese, ItalyJ. De Sousa / Lisbon, PortugalJ.C. Deharo / Marseille, France
8
Faculty
M. Del Greco / Trento, ItalyA. Dello Russo / Milan, ItalyP. Delise / Conegliano Veneto, ItalyL. Di Biase / New York, USAM. Di Biase / Foggia, ItalyG. Di Pasquale / Bologna, ItalyM. Disertori / Trento, ItalyP. Dorian / Toronto, CanadaF.R. Dorticòs Balea / La Havana, CubaF. Drago / Rome, ItalyS. Dubner / Buenos Aires, ArgentinaJ.R. Edgerton / Dallas, USAN.E. El-Sherif / New York, USAZ. Emkanjoo / Tehran, IranA.E. Epstein / Philadelphia, USAM. Eslami / Tehran, IranI. Fernandez Lozano / Madrid, SpainA. Ferrick / New York, USAM. Figueiredo / Sao Paolo, BrazilG.M. Francese / Catania, ItalyA. Fuenmayor / Mérida, VenezuelaN. Gadhok / London, UKF. Gaita / Turin, ItalyN. Galizio / Buenos Aires, ArgentinaM.J. Garcia / New York, USAT. Gaspar / Dresden, GermanyM. Gasparini / Rozzano, ItalyF. Giada / Noale, ItalyA.M. Gillis / Calgary, CanadaA. Goette / Paderborn, GermanyM.R. Gold / Charleston, USAA. Gonzalez-Hermosillo / Mexico City, MexicoM. Grimaldi / Acquaviva delle Fonti, ItalyP. Guerra / Montreal, CanadaM.M. Gulizia / Catania, ItalyD. Hachul / Sao Paulo, BrazilM. Haïssaguerre / Bordeaux, France
R. Hatala / Bratislava, Slovak RepublicR.N.W. Hauer / Utrecht, The NetherlandsJ. Healey / Hamilton, CanadaJ. Hebe / Bremen, GermanyH. Heidbüchel / Leuven, BelgiumJ.M.L. Hendriks / Maastricht, The NetherlandsG. Hindricks / Leipzig, GermanyK. Hirao / Tokyo, JapanS.Y. Ho / London, UKM. Hocini / Bordeaux, FranceS.H. Hohnloser / Frankfurt, GermanyH. Honjo / Nagoya, JapanM.G. Hoogendijk / Nieuwegein, The NetherlandsD.J. Huang / Chengdu, ChinaH.V. Huikuri / Oulu, FinlandS. Iliceto / Padua, ItalyM. Imazio / Turin, ItalyP. Jaïs / Bordeaux, FranceC. Jazra / Beirut, LebanonB. Jennings / Kalamazoo, USAJ. Jerrome / Stratford-upon-Avon, UKW. Jung / Villingen, GermanyA. Kakkar / London, UKC. Karmelic / Santiago, ChileJ. Kautzner / Prague, Czech RepublicR. Keegan / Bahia Blanca, ArgentinaC. Kennergren / Gothenburg, SwedenR.A. Kenny / Dublin, IrelandM. Khoury / Beirut, LebanonA. Kilic / Ankara, TurkeyY.H. Kim / Seoul, KoreaP. Kirchhof / Birmingham, UKJ. Kirsch / Toronto, CanadaH. Klein / Rochester, USAH. Kottkamp / Zürich, SwitzerlandA.D. Krahn / Vancouver, CanadaK.H. Kuck / Hamburg, Germany
Program Chairs
9 Advance Program
Faculty
G. Kudaiberdieva / Bishkek, KyrgyzstanK. Kusano / Osaka, JapanS.P. Kutalek / Philadelphia, USAA. Kutarski / Lublin, PolandM. La Meir / Maastricht, The NetherlandsM.T. La Rovere / Montescano, ItalyK.H. Ladwig / Munich, GermanyD. Lakkireddy / Kansas City, USAP. Lambiase / London, UKM. Lane / Austin, USAD. Lau / Maastricht, The NetherlandsC.P. Lau / Hong Kong, ChinaA. Leenhardt / Paris, FranceR. Lenarczyk / Zabrze, PolandS. Lévy / Marseille, FranceT. Lewalter / Munich, GermanyB.S. Lewis / Haifa, IsraelC. Linde / Stockholm, SwedenG.Y.H. Lip / Birmingham, UKC.F. Liu / New York, USAU. Livi / Udine, ItalyT. Lobban / Stratford-upon-Avon, UKC. Love / Columbus, USAS. Lovison / Venice-Mestre, ItalyB. Lüderitz / Bonn, GermanyM. Lunati / Milan, ItalyP. Mabò / Rennes, FranceP.A. Macfarlane / Glasgow, UKM. Madalosso / Venice-Mestre, ItalyA. Majiluf / Mexico City, MexicoN. Makita / Nagasaki, JapanD. Mangino /Venice-Mestre, ItalyM. Mansour / Boston, USAR. Mantovan / Cesena, ItalyF.E. Marchlinski / Philadelphia, USAF. Marin / Murcia, SpainB.J. Maron / Minneapolis, USA
M.S. Maron / Boston, USAM. Marquez / Mexico City, MexicoA. Mazzanti / Pavia, ItalyL. Menicanti / San Donato Milanese, ItalyJ.L. Merino / Madrid, SpainT. Metz / Columbus, USAP. Mitkowski / Poznan, PolandS. Mittal / New York, USAL. Molina / Mexico City, MexicoC. Monreal / Austin, USAL. Mont / Barcelona, SpainC. Morais / Lisbon, PortugalJ.M. Morgan / Southampton, UKL. Morichelli / Rome, ItalyC.A. Morillo / Hamilton, CanadaA. Moya / Barcelona, SpainF. Musumeci / Rome, ItalyH. Nakagawa / Oklahoma City, USAC. Napolitano / Pavia, ItalyS.M. Narayan / San Diego, USAA. Natale / Austin, USAS. Nisam / Bierges, BelgiumE. Occhetta / Novara, ItalyK. Okumura / Hirosaki, JapanM.M. Oliveira / Lisbon, PortugalB. Olshansky / Iowa City, USAO. Oseroff / Buenos Aires, ArgentinaA. Oto / Ankara, TurkeyE.I. Ovsyshcher / Beer-Sheva, IsraelD.L. Packer / Rochester, USAL. Padeletti / Florence, ItalyR.L. Page / Madison, USAC. Pandozi / Rome, ItalyC. Pappone / Cotignola, ItalyG. Pelargonio / Rome, ItalyA. Pelliccia / Rome, ItalyM. Perazzolo Marra / Padua, Italy
10
G. Perego / Milan, ItalyN.S. Peters / London, UKM. Piacenti / Pisa, ItalyE. Picano / Pisa, ItalyL. Plebani / Novara, ItalyE. Polesel / Treviso, ItalyP. Postema / Amsterdam, The NetherlandsT. Potpara / Belgrade, SerbiaJ. Primo / Lisbon, PortugalA. Proclemer / Udine, ItalyE.N. Prystowsky / Indianapolis, USAJ.L. Ramos / Rosario, ArgentinaA. Ravikishore / Bangalore, IndiaA. Raviele / Venice-Mestre, ItalyA. Revishvili / Moscow, RussiaN. Reyes / Puebla, MexicoW. Reyes Caorsi / Montevideo, UruguayR.P. Ricci / Rome, ItalyF. Rigo / Venice-Mestre, ItalyG. Rodriguez Diez / Santa Fe, MexicoV. Roldan / Murcia, SpainE. Rosenthal / London, UKA. Rossillo / Venice-Mestre, ItalyR. Rosso / Tel Aviv, IsraelA.M. Russo / Cherry Hill, USAE. Saad / Rio de Janeiro, BrazilE. Saarel / Salt Lake City, USAF. Sacher / Bordeaux, FranceL.C. Saenz Morales / Bogotà, ColombiaA. Sagone / Milan, ItalyS. Saksena / New Brunswick, USAL. Salvador / Vicenza, ItalyP. Santangeli / Philadelphia, USAM. Santini / Rome, ItalyM. Santomauro / Naples, ItalyJ.L. Sapp / Halifax, CanadaI. Savelieva / London, UK
M. Scaglione / Asti, ItalyM. Scanavacca / Sao Paulo, BrazilB. Schaer / Basel, SwitzerlandP. Schauerte / Berlin, GermanyM.M. Scheinman / San Francisco, USAR.A. Schweikert / Akron, USAL.R. Scott / Phoenix, USAK.K. Sethi / New Delhi, IndiaD. Shah / Geneva, SwitzerlandS. Sharma / London, UKR.S. Sheldon / Calgary, CanadaW.K. Shen / Phoenix, USAM. Shenasa / San José, USAK. Shivkumar / Los Angeles, USAB. Singh / Gurgaon, IndiaD.C.W. Siu / Hong Kong, ChinaD.J. Slotwiner / New York, USAK. Soejima / Kawasaki, JapanJ. Sra / Milwaukee, USAJ. Steffel / Zürich, SwitzerlandG. Steinbeck / Munich, GermanyJ.S. Steinberg / New York, USAE. Sternick / Belo Horizonte, BrazilL.W. Stevenson / Boston, USAW.G. Stevenson / Boston, USAM.J. Strieper / Atlanta, USAR. Sueidan / Jiddah, KSAR. Sutton / Montecarlo, MonacoR. Sweidan / Jeddah, Saudi ArabiaM. Taborsky / Olomouc, Czech RepublicM. Takagi / Osaka, JapanC. Teckenbrock / Austin, USAJ. Tfelt-Hansen / Copenhagen, DenmarkS. Themistoclakis / Venice-Mestre, ItalyG. Thiene / Padua, ItalyB. Thomas / Austin, USAC. Tondo / Milan, Italy
Faculty
Program Chairs
11 Advance Program
D. Toni / Rome, ItalyM. Tritto / Castellanza, ItalyG. Turitto / New York, USAA. Ungar / Florence, ItalyW. Uribe / Medellin, ColombiaJ.G. Van Dijk / Leiden, The NetherlandsR. Ventura / Bremen, GermanyA. Venturini / Venice-Mestre, ItalyR. Verlato / Camposampiero, ItalyA. Verma / Toronto, CanadaE.G. Vester / Düsseldorf, GermanyR. Wakili / Munich, GermanyA. Waldo / Cleveland, USAA.A. Wilde / Amsterdam, The NetherlandsB.L. Wilkoff / Cleveland, USAS. Willems / Hamburg, GermanyJ. Winter / Düsseldorf, GermanyC.G. Wollmann / St. Poelten, AustriaC. Wolpert / Ludwigsburg, GermanyT. Wong / London, UKJ.K. Wranicz / Lodz, PolandY. Yamauchi / Tokyo, JapanF. Zanon / Rovigo, ItalyW. Zareba / Rochester, USAM. Zecchin / Trieste, ItalyK. Zedlitz / Austin, USAK. Zeppenfeld / Leiden, The NetherlandsP. Zeppilli / Rome, ItalyS. Zhang / Beijing, ChinaG. Zoffoli / Venice-Mestre, Italy
Faculty
This faculty list may change due to pending confirmation from invited speakers.
12
Faculty
13 Advance Program
GeneralScientific Overview
14
Featured Symposia
Atrial Fibrillation from A to ZElectrogenetic and clinical issues
October 27 - Arazzi Room Program ChairmenAndrea Natale / Austin, USAAntonio Raviele / Venice-Mestre, Italy
- New insights in the mechanism of AF- AF: “hot” clinical topics- AA drug prevention of AF: recent advances- Indications to new oral anticoagulants in AF
Atrial Fibrillation from A to ZAblation issues
October 28-29 - Arazzi Room Program ChairmenAndrea Natale / Austin, USAAntonio Raviele / Venice-Mestre, Italy
- New AF mapping and ablation techniques- AF ablation controversies: 1. anticoagulation issues- AF ablation controversies: 2. procedural issues- AF ablation controversies: 3. clinical issues- Value of AF ablation in different clinical settings (1)- Value of AF ablation in different clinical settings (2)
Program Chairs
15 Advance Program
Main Symposia / Core Curricula
AF clinical trials update 2013
October 28 - Cenacolo Room Program ChairmenStuart J. Connolly / Hamilton, Canada Stefan H. Hohnloser / Frankfurt, Germany
- Stroke prevention in AF: particular issues- AF registries- AF therapy trials
Anatomy of the heart for electrophysiologists
October 27 - Cenacolo RoomProgram ChairmenCristina Basso / Padua, ItalySiew Yen Ho / London, UK
- Anatomy of the heart relevant to SVT and AF- Anatomy for resynchronization therapy
Anti-thrombotic therapy for cardiac arrhythmias
October 28 - Arazzi Room Program ChairmenJohn A. Camm / London, UKGregory Y.H. Lip / Birmingham, UK
- State of the art lectures on AF and thromboembolism. How to use the new oral anticoagulants for stroke prevention in AF- Practical aspects on stroke prevention in atrial firbrillation – What to do?
16
Main Symposia / Core Curricula
Arrhythmias in adults with congenital heart disease: beyond evidence-based medicine
October 28 - Barbantini Room Program ChairmenJoachim Hebe / Bremen, GermanyRodolfo ventura / Bremen, Germany
- Mechanisms and prevention of arrhythmias- Therapeutic challenges
Arrhythmias in the elderly
October 29 - Consiglio RoomProgram Chairmen Andrew E. Epstein / Philadelphia, USAWin-Kuang Shen / Phoenix, USA
- Practical issues: a case-based approach
Arrhythmogenic right ventricular dysplasia / cardiomyopathy
October 28 - Carnelutti RoomProgram ChairmanRichard N.W. Hauer / Utrecht, The Netherlands
- ARVD/C: from gene to therapy
Asymptomatic AF
October 28 - Borges RoomProgram ChairmanSanjeev Saksena / New Brunswick, USA
- Silent AF: detection, prognosis and interventions
Program Chairs
17 Advance Program
Main Symposia / Core Curricula
Cardiac arrhythmias surgery
October 29 - Cenacolo Room Program ChairmenRalph J. Jr. Damiano / St. Louis, USADomenico Mangino / Venice-Mestre, Italy
- Concomitant AF surgical ablation- Lone AF surgical ablation- Cardiac arrhythmias in patients candidate to surgery: controversial issues
Contemporary and controversial issues in cardiac pacing
October 29 - Cipressi Room Program ChairmenAndrew E. Epstein / Philadelphia, USA Eli I. Ovsyshcher / Beer-Sheva, Israel
- Technological issues- Clinical issues
CRT: pre-implant, implant & post-implant issues
October 29 - Cipressi RoomProgram ChairmanSanjeev Saksena / New Brunswick, USA
- Optimization of CRT therapy
Heart failure and cardiac resynchronization therapy
October 28 - Cipressi Room Program Chairmen Angelo Auricchio / Lugano, Switzerland Michael R. Gold / Charleston, USA
- Individualizing cardiac resynchronization therapy delivery (1)- Individualizing cardiac resynchronization therapy delivery (2)
18
Main Symposia / Core Curricula
Hereditary arrhythmogenic syndromes
October 27 - Carnelutti Room Program Chairmen Sami viskin / Tel Aviv, IsraelArthur A. Wilde / Amsterdam, The Netherlands
- Back to basics: understanding ventricular repolarization in the ECG- Early repolarization and arrhythmias: mith or reality?- Catecholaminergic polymorphic VT: understanding this killer- Those left behind: what to do with the relatives of sudden death victim?
Lead extraction and device infection
October 27 - Barbantini Room Program ChairmenMaria Grazia Bongiorni / Pisa, ItalyCharles Kennergren / Gothenburg, Sweden
- Clinical lead management issues- Lead extraction: a European perspective
Mechanisms and ablation of cardiac arrhythmias
October 28 - Consiglio Room Program ChairmenWarren M. Jackman / Oklahoma City, USAMelvin M. Scheinman / San Francisco, USA
- Mechanisms & value of EP study- Ablation of cardiac arrhythmias
Program Chairs
19 Advance Program
Main Symposia / Core Curricula
Modern management of AF
October 28 - Borges RoomProgram ChairmenStuart J. Connolly / Hamilton, CanadaPaul Dorian / Toronto, Canada
- Improving the continuum of care in patients with AF: how can we make it systematic?
New technologies and techniques in catheter ablation
October 28 - PiccoloTeatro Room Program Chairmen Francis E. Marchlinski / Philadelphia, USASakis Themistoclakis / Venice-Mestre, Italy
- Mapping, imaging, ablating: what’s new?
Non-invasive evaluation of arrhythmias
October 29 - Carnelutti RoomProgram Chairmen Nabil E. El-Sherif / New York, USAMaria Teresa La Rovere / Montescano, Italy
- Non invasive risk markers of arrhythmic death
Pediatric aspects of cardiac arrhythmias
October 28 - Barbantini Room Program ChairmenBulent Gorenek / Eskisehir, TurkeyMargaret J. Strieper / Atlanta, USA
- Management of cardiac arrhythmias in pediatric age
20
Main Symposia / Core Curricula
Present your most challenging cases - Rising stars and more
October 29 - Consiglio RoomProgram ChairmenLuigi Di Biase / New York, USAAntonio Rossillo / Venice-Mestre, Italy
- Supraventricular arrhythmias- Ventricular arrhythmias
Remote monitoring of cardiac arrhythmias / devices
October 27 - Cipressi Room Program ChairmenJonathan S. Steinberg / New York , USABruce L. Wilkoff / Cleveland, USA
- Remote monitoring: technical, practical, economic issues
Role of cardiac imaging in electrophysiology
October 28 - Piccolo Teatro Room Program Chairmen David Callans / Philadelphia, USASabino Iliceto / Padua, Italy
- Role of cardiac imaging in electrophysiology
Program Chairs
21 Advance Program
Main Symposia / Core Curricula
Sport and arrhythmias
October 27 - Piccolo Teatro Room Program ChairmenFranco Giada / Noale, ItalyBarry J. Maron / Minneapolis, USA
- Novel diagnostic examinations in the evaluation of athletes at risk of sudden death - ECG screening and detection of cardiac disease- Difficult cases: let’s discuss together- Hot topics and controversies in arrhythmias & sports
Sudden Cardiac Death, ICD and Surroundings
October 27 - Cipressi Room Program Chairmen Günter Breithardt / Münster, GermanyEric N. Prystowsky / Indianapolis, USA
- Reducing SCD around the world: problems and potential solutions- ICD: technical, clinical & ethical aspects
Syncope 2013 update
October 29 - Piccolo Teatro RoomProgram ChairmenDavid G. Benditt / Minneapolis, USABrian Olshansky / Iowa City, USA
- Pathophysiology of syncope- Clinical evaluation and risk stratification- Diagnostic investigation of specific conditions- Syncope: dilemmas
22
Main Symposia / Core Curricula
Value of ICE for the electrophysiologists
October 28 - Piccolo Teatro RoomProgram ChairmanSanjeev Saksena / New Brunswick, USA
- Intracardiac echocardiography: advances in techniques and applications
Vasovagal syncope
October 28 - Piccolo Teatro RoomProgram ChairmenPaolo Alboni / Ferrara, ItalyJean Jacques Blanc / Brest, France
- Neglected aspects of vasovagal syncope
Program Chairs
23 Advance Program
International Scientific Societies Corners
APHRS Corner
October 29 - Carnelutti RoomProgram Chairmen Shih-Ann Chen / Taipei, TaiwanYoung-Hoon Kim / Seoul, Korea
- RVOT tachycardia: benign tachycardia or early stage ARVD/C tachycardia?
CHRS Corner
October 28 - Barbantini RoomProgram ChairmenPeter Guerra / Montreal, CanadaAtul verma / Toronto, Canada
- Controversies in catheter ablation and EP training
ECAS Corner
October 29 - Barbantini RoomProgram ChairmenRiccardo Cappato / San Donato Milanese, ItalyDipen Shah / Geneva, Switzerland
- Latest news in the evaluation and management of cardiac arrhythmias
24
International Scientific Societies Corners
EHRA Corners
October 28 - Cipressi RoomOctober 28 - Borges RoomProgram ChairmenAndreas Goette / Paderborn, GermanyJohn M. Morgan / Southampton, UK
- Optimal therapy in patients with heart failure- Translational approaches in persistent atrial fibrillation
HRS Corners
October 27 - Cenacolo RoomOctober 27 - Barbantini RoomProgram ChairmenHugh Calkins / Baltimore, USAAnne M. Gillis / Calgary, Canada
- State of the art in atrial fibrillation management 2013 - CIED lead management strategies
ISHNE Corner
October 27 - Cipressi RoomProgram ChairmenPeter H. Stone / Boston, USAWojciech Zareba / Rochester, USA
- Reducing inappropriate ICD therapy in light of MADIT-RIT
Program Chairs
25 Advance Program
International Scientific Societies Corners
JHRS Corner
October 28 - Carnelutti RoomProgram ChairmenKenzo Hirao / Tokyo, JapanYuji Nakazato / Tokyo, Japan
- Diagnosis and treatment of idiopathic ventricular arrhythmias
SOLAECE Corner 1
October 28 - Carnelutti RoomProgram ChairmenLuis Aguinaga / Tucuman, Argentina Guilherme Fenelon / Sao Paulo, Brazil
- Ablation of ventricular complex substrates
SOLAECE Corner 2
October 27 - Borges RoomOctober 29 - Carnelutti RoomProgram ChairmenLuis Molina / Mexico City, MexicoDiego vanegas / Bogotà, Colombia
- Maximizing use of technology- Right ventricular outflow tract tachycardias
WSA Corner
October 28 - Cenacolo RoomProgram ChairmenMassimo Santini / Rome, ItalyPanos E. vardas / Heraklion, Greece
- Atrial fibrillation: heterogeneity of the optimal treatment worldwide
26
Geographic Area Corners
Argentinian Corner
October 29 - Carnelutti RoomProgram ChairmenNestor Galizio / Buenos Aires, ArgentinaOscar Oseroff / Buenos Aires, Argentina
- Primary cardiomyopathies and channelopathies: new aspects in risk stratification, prognosis and treatment
Brazilian Corner
October 29 - Barbantini RoomProgram ChairmenEduardo Saad / Rio de Janeiro, BrazilMauricio Scanavacca / Sao Paulo, Brazil
- Epicardial access for VT ablation: how it can help solving complex problems. An interactive case-based approach
Chinese Corner
October 27 - Cenacolo RoomProgram ChairmenChu-Pak Lau / Hong Kong, ChinaShu Zhang / Beijing, China
- Racial influence on AF susceptibility
French Corner
October 28 - Consiglio RoomProgram ChairmenEtienne Aliot / Vandoeuvre-lès-Nancy, FranceJean Jacques Blanc / Brest, France
- Daily challenges in asymptomatic patients: from case reports to guidelines
Program Chairs
27 Advance Program
Geographic Area Corners
German Corner
October 27 - Barbantini RoomProgram ChairmenMartin Borggrefe / Mannheim, GermanyWerner Jung / Villingen, Germany
- Novel pacing strategies
Indian Corners
October 28 - Borges RoomOctober 29 - Cipressi RoomProgram ChairmenSanjeev Saksena / New Brunswick, USAKamal K. Sethi / New Delhi, India
- The left atrial appendage: new insights & interventions- CRT: electrocardiography, patient selection and optimal application in emerging nations
Japanese Corner
October 28 - Carnelutti RoomProgram ChairmenHiroshi Nakagawa / Oklahoma City, USAYuji Nakazato / Tokyo, Japan
- Revisit of Brugada syndrome: from basic mechanism to catheter ablation
28
Mexican Corner
October 27 - Barbantini RoomProgram ChairmenLuis Molina / Mexico City, MexicoNicolas Reyes / Puebla, Mexico
- The use of new anticoagulants in Mexico
Middle East Corner
October 29 - Barbantini RoomProgram ChairmenCharles Jazra / Beirut, LebanonMaurice Khoury / Beirut, Lebanon
- Peculiar issues in the management of cardiac arrhythmias in Middle East
Persian Corner
October 27 - Borges RoomProgram ChairmenAli Massumi / Houston, USA Mohammad Shenasa / San José, USA
- AF treatment in Iran: contemporary issues
Polish Corner
October 27- Borges RoomProgram ChairmenJerzy K. Wranicz / Lodz, PolandWojciech Zareba / Rochester, USA
- Innovative approaches in device management
Geographic Area Corners
Program Chairs
29 Advance Program
Portuguese Corner
October 29 - Borges RoomProgram ChairmenPedro Adragão / Carnaxide, PortugalCarlos Morais / Lisboa, Portugal
- AF ablation: Portuguese experience
Russian Corner
October 29 - Cenacolo RoomProgram ChairmenAndrey Ardashev / Moscow, RussiaAmiran Revishvili / Moscow, Russia
- Ablation, surgery and hybrid approaches for treatment of long-standing persistent atrial fibrillation
Spanish Corner
October 29 - Borges RoomProgram ChairmenJosé L. Merino / Madrid, SpainLluis Mont / Barcelona, Spain
- “Hot EP topics” in Spain in 2013: economy, clinical results, accreditation & organization
Geographic Area Corners
30
Allied professionals program
October 27 - Consiglio RoomProgram ChairmenStefania Damiani / Venice-Mestre, ItalyBarbara Thomas / Austin, USA
- Insights into the management of complex arrhythmias in the EP lab- Hot topics in 2013- Atrial fibrillation today
Patients association program
October 27 - Consiglio RoomProgram ChairmanTrudie Lobban / Stratford-upon-Avon, UK
- How to improve the management of cardiac arrhythmias: role of advocacy and patient education
Other Corners
Program Chairs
31 Advance Program
Satellite Symposia and Luncheon Panels
Bayer Luncheon Panel
October 28 - Cenacolo Room- Stroke prevention in atrial fibrillation: the role of rivaroxaban
Boehringer Ingelheim Luncheon Panel
October 27 - Arazzi Room- Dabigatran from clinical trials to real world: what has changed?
Medtronic Emerging leaders Luncheon Panel
October 28 - Cipressi Room- Emerging leaders in electrophysiology: case presentation and discussion
Medico Satellite Symposium
October 28 - Consiglio Room- Can haemodynamic sensing improve the pacing therapy in the remote monitoring era?
Sorin Group Luncheon Panel
October 28 - Carnelutti Room- CRT goals and issues: the experts’ point of view
St. Jude Medical Satellite Symposium
October 28 - Cipressi Room- Fluoroscopy exposure during ablation procedures and device implantation: reducing the risk for patients and clinicians
32
Arazzi Room
32
33 Advance Program
DetailedScientific Program
Arazzi Room
34
Sunday 27 morning - Arazzi Room
Atrial fibrillation from A to Z
8.30-10.30NEW INSIGHTS IN THE MECHANISM OF AF
Chairmen: M. Di Biase / Foggia, Italy - H. Nakagawa / Oklahoma City, USA
Genetics of AF: what’s new?M. Disertori / Trento, Italy
Stable AF rotors and complex fractionated atrial electrograms: which relationship?S.M. Narayan / San Diego, USA
Does lone AF mean fibrotic atrial cardiomyopathy?H. Kottkamp / Zurich, Switzerland
Vagal and sympathetic AF: do they really exist?S. Lévy / Marseille, France
AF-induced cardiomyopathy: do we know the mechanism?A. Goette / Paderborn, Germany
Atrial fibrillation from A to Z
10.45-12.45AF: “HOT” CLINICAL TOPICS
Chairmen: P.E. Bloch-Thomsen / Hellerup, Denmark - L. Padeletti / Florence, Italy
Alcohol and risk of developing AF: mith or reality?B. Lüderitz / Bonn, Germany
AF may cause dementia: evidence from the literatureP. Santangeli / Philadelphia, USA
Chronic kidney disease and AF: prevalence, causes and consequencesI. Savelieva / London, UK
AF and heart failure: how to interrupt the vicious circle?T. Wong / London, UK
Patients with cardioembolic events during effective oral anticaogulation: can the AF ablation or LAA closure procedures be the solution?M. Mansour / Boston, USA
35 Advance Program
Boehringer Ingelheim Luncheon Panel
12.45-14.00DABIGATRAN FROM CLINICAL TRIALS TO REAL WORLD: WHAT HAS CHANGED?
Chairmen: G.Y.H. Lip / Birmingham, UK - A. Raviele / Venice-Mestre, Italy
The uniqueness of dabigatran: real life confirms clinical studiesS.J. Connolly / Hamilton, Canada
Practical guide to the use of dabigatran in different clinical settingsR. Cappato / San Donato Milanese, Italy
Indications to dabigatran: what do the guidelines say?S.H. Hohnloser / Frankfurt, Germany
Sunday 27 afternoon - Arazzi Room
36
Sunday 27 afternoon - Arazzi Room
Atrial fibrillation from A to Z
14.00-16.00AA DRUG PREvENTION OF AF: RECENT ADvANCES
Chairmen: G.L. Botto / Como, Italy - C. Jazra / Beirut, Lebanon
Short-term AAD treatment after cardioversion of AF: is lesser better?P. Kirchhof / Birmingham, UKDronedarone: just another option or real progress?A. Capucci / Ancona, ItalyRanolazine for prevention of AF: hope or hype?C. Antzelevitch / Utica, USAOmega-3 fatty acids to prevent AF: another promise not fulfilled?L. Calò / Rome, ItalyAldosterone antagonists for prevention of AF: the revenge of “up-stream” therapy?M. Disertori / Trento, Italy
Atrial fibrillation from A to Z
16.00-18.00INDICATIONS TO NEW ORAL ANTICOAGULANTS IN AF
Chairmen: M.M. Gulizia / Catania, Italy - J. Healey / Hamilton, Canada
Should new oral anticoagulants be used as first-line therapy in all patients?PRO: R. Hatala / Bratislava, Slovak RepublicCON: A.L. Waldo / Cleveland, USA
Oral anticoagulants (warfarin or newer ones) should not be given to all patients with CHA2DS2-VASc=1PRO: G. Di Pasquale / Bologna, ItalyCON: D.G. Benditt / Minneapolis, ItalySpecific indications to the different new oral anticoagulants- Dabigatran R. De Caterina / Chieti, Italy- Rivaroxaban G. Breithardt / Münster, Germany- Apixaban R.L. Page / Madison, USA
37 Advance Program
Opening Ceremony
18.00-19.30OPENING CEREMONY
•Welcomeaddress
•Presidents’address
•GreetingsofPoliticalandAdministrativeAuthorities
•GreetingsfromtheInternationalScientificSocietiesRepresentatives
•Awards - Distinguished Scientist - Distinguished Teacher - Others
Sunday 27 afternoon - Arazzi Room
38
Monday 28 morning - Arazzi Room
Anti-thrombotic therapy for cardiac arrhythmias8.30-10.30STATE OF THE ART LECTURES ON AF AND THROMBOEMBOLISMChairmen: A.J. Camm / London, UK - A.L. Waldo / Cleveland, USALecture 1. Mechanisms of thrombogenesis in AF: insights from experimental models and geneticsv. Roldan / Murcia, SpainLecture 2. Stroke and bleeding risk assessment: where are we now?G.Y.H. Lip / Birmingham, UK
HOW TO USE THE NEW ORAL ANTICOAGULANTS FOR STROKE PREvENTION IN AF Chairmen: A.J. Camm / London, UK - A.L. Waldo / Cleveland, USAAn overview of the new oral anticoagulants for stroke prevention in AF R. De Caterina / Chieti, ItalyWhat do the guidelines say and what should updates modify?J. Healey / Hamilton, Canada
Anti-thrombotic therapy for cardiac arrhythmias11.00-13.00PRACTICAL ASPECTS ON STROKE PREvENTION IN ATRIAL FIBRILLATION - WHAT TO DO?Chairmen: H. Heidbüchel / Leuven, Belgium - G.Y.H. Lip / Birmingham, UKMy patient on oral anticoagulation has a high stroke and bleeding risk - what to do?T. Potpara / Belgrade, SerbiaMy patient gets a thromboembolic event despite well controlled warfarinG. Hindricks / Leipzig, GermanyMy patient with AF presents with an acute coronary syndrome and needs a stentB.S. Lewis / Haifa, IsraelMy patient taking a novel oral anticoagulant needs surgery, device implantation or ablationA.J. Camm / London, UKMy patient on dabigatran presents with an ischaemic stroke, and is being considered for thrombolysisD. Toni / Rome, ItalyMy patient taking a novel oral anticoagulant presents major GI bleedingF. Marin / Murcia, Spain
39 Advance Program
Monday 28 afternoon - Arazzi Room
Atrial fibrillation from A to Z
14.30-16.30NEW AF MAPPING AND ABLATION TECHNIQUES
Chairmen: P. Adragão / Carnaxide, Portugal - D.L. Packer / Rochester, USANon-invasive panoramic mapping to assess the underlying mechanisms of AFM. Haïssaguerre / Bordeaux, France“FIRM” technique to localize focal sources and rotors and guide AF ablationK. Shivkumar / Los Angeles, USAPV isolation with visually guided laser balloon catheter: feasibility and resultsK.H. Kuck / Hamburg, GermanyAF ablation by using contact force-sensing catheter: tool or toy?J. Kautzner / Prague, Czech RepublicAF ablation with circular irrigated multi-electrode catheter: efficacy and safety M. Grimaldi / Acquaviva delle Fonti, Italy Will electrophysiologists play ball? The ablating EP’s perspectiveN.S. Peters / London, UK
Atrial fibrillation from A to Z
17.00-19.00AF ABLATION CONTROvERSIES: 1. ANTICOAGULATION ISSUES
Chairmen: H. Kottkamp / Zurich, Switzerland - S. Themistoclakis / Venice-Mestre, Italy
Should pre-procedural transesophageal echocardiography be performed in all patients including those at low thrombo-embolic risk? PRO: E. Bertaglia / Padua, ItalyCON: Y.H. Kim / Seoul, Korea
AF ablation under therapeutic warfarin should be preferred to warfarin discontinuation with peri-procedural bridging with heparinPRO: L. Di Biase / New York, USACON: R. Cappato / San Donato Milanese, Italy
Oral anticoagulation may be safely stopped after apparently successful AF ablationPRO: D. Lakkireddy / Kansas City, USACON: S.A. Chen / Taipei, Taiwan
40
Tuesday 29 morning - Arazzi Room
Atrial fibrillation from A to Z
8.30-10.30AF ABLATION CONTROvERSIES: 2. PROCEDURAL ISSUES
Chairmen: S.A. Chen / Taipei, Taiwan - C. Pappone / Cotignola, Italy
AF termination / inducibility are not of great value in predicting clinical outcomePRO: D.L. Packer / Rochester, USACON: Y.H. Kim / Seoul, Korea
Elimination of triggers without an additional substrate modification is not sufficient in patients with persistent AFPRO: S. Willems / Hamburg, GermanyCON: D. Callans / Philadelphia, USA
Should adenosine test be performed systematically at the end of AF ablation procedure?PRO: R. De Ponti / Varese, ItalyCON: N.S. Peters / London, UK
Atrial fibrillation from A to Z
11.00-13.00AF ABLATION CONTROvERSIES: 3. CLINICAL ISSUES
Chairmen: K.H. Kuck / Hamburg, Germany - A. Raviele / Venice-Mestre, Italy
Silent cerebral micro-embolisms detected by MRI following AF ablation are clinically insignificant findingsPRO: W. Jung / Villingen, Germany CON: F. Gaita / Turin, Italy
Ablation should be first-line therapy in all patients with paroxysmal AF PRO: A. Natale / Austin, USACON: P. Dorian / Toronto, Canada
Very long-term results of AF ablation confirm that this therapy is really effectivePRO: D. Callans / Philadelphia, USACON: S. Lévy / Marseille, France
41 Advance Program
Tuesday 29 afternoon - Arazzi Room
Atrial fibrillation from A to Z
14.30-16.30vALUE OF AF ABLATION IN DIFFERENT CLINICAL SETTINGS (1)
Chairmen: M. Hocini / Bordeaux, France - A. Rossillo / Venice-Mestre, Italy
Coronary heart diseaseR.A. Schweikert / Akron, USA
Hypertrophic cardiomyopathyL. Di Biase / New York, USA
Valvular heart diseaseA. verma / Toronto, Canada
LV disfunction / heart failureT. Wong / London, UK
Patients with pacemaker / ICDA. Proclemer / Udine, Italy
Atrial fibrillation from A to Z
17.00-19.00vALUE OF AF ABLATION IN DIFFERENT CLINICAL SETTINGS (2)
Chairmen: A. Bonso / Feltre, Italy - R.A. Schweikert / Akron, USA
Obesity / diabetes / metabolic syndromeJ.D. Burkhardt / Austin, USA
Obstructive sleep apneaA. verma / Toronto, Canada
Chronic pulmonary obstructive diseaseD. Lakkireddy / Kansas City, USA
Chronic kidney disease / hemodialysisC. Tondo / Milan, Italy
The elderlyP. China / Venice-Mestre, Italy
42
Cenacolo Room
42
43 Advance Program
DetailedScientific Program
Carnelutti Room
44
Sunday 27 morning - Carnelutti Room
Hereditary Arrhythmogenic Syndromes
8.30-10.30BACK TO BASICS: UNDERSTANDING vENTRICULAR REPOLARIZATION IN THE ECG
Chairmen: E. Behr / London, UK - A.A. Wilde / Amsterdam, The Netherlands
Cellular basis for early repolarization and J-waveC. Antzelevitch / Utica, USA
The basis of T-wave and ST segmentP. Delise / Conegliano Veneto, Italy
The basis of the U-waveP. Postema / Amsterdam, The Netherlands
Hereditary Arrhythmogenic Syndromes
10.45-12.45EARLY REPOLARIZATION AND ARRHYTHMIAS: MITH OR REALITY?
Chairmen: C. Antzelevitch / Utica, USA - M.M. Scheinman / San Francisco, USA
Introduction to the debatesRules of engagement: can we concentrate on the essence and not on terminology?R. Rosso / Tel Aviv, Israel
Debate 1. Early Repolarization and idiopathic vF
Patients with J-waves are prone to die suddenlyF. Sacher / Bordeaux, France
Patients with J-waves should be left aloneP.W. MacFarlane / Glasgow, UK
Debate 2. Early Repolarization in long-term population studies
Early repolarization predicts arrhythmic deathH.v. Huikuri / Oulu, Finland
Early repolarization is a sign of good healthP. Postema / Amsterdam, The Netherlands
45 Advance Program
Sunday 27 afternoon - Carnelutti Room
Hereditary Arrhythmogenic Syndromes14.00-16.00CATECHOLAMINERGIC POLYMORPHIC vT: UNDERSTANDING THIS KILLER
Chairmen: M.J. Ackerman / Rochester, USA - R. Rosso / Tel Aviv, Israel
Pathophysiology of CPVT: what genetics tells usA. Mazzanti / Pavia, Italy
Decoding a CPVT genetic test resultM.J. Ackerman / Rochester, USA
Risk stratification in humans: what the clinical data tell usA. Leenhardt / Paris, France Therapeutic optionsA.A. Wilde / Amsterdam, The Netherlands
Hereditary Arrhythmogenic Syndromes16.00-18.00THOSE LEFT BEHIND: WHAT TO DO WITH THE RELATIvES OF SUDDEN DEATH vICTIM?
Chairmen: M. Disertori / Trento, Italy - A.D. Krahn / Vancouver, Canada
Molecular genetics: when is a mutation disease causing?C. Napolitano / Pavia, Italy
Phenotypic screening of family members: how far to go?E. Behr / London, UK
Genotypic screening of family members: how far to go? M.J. Ackerman / Rochester, USA
Resisting the pressures: when is ICD indicated for those left behind?LQTS, SQTS, BrugadaA.A. Wilde / Amsterdam, The Netherlands
Hypertrophic and dilated cardiomyopathies F. Cecchi / Florence, Italy
46
Monday 28 morning - Carnelutti Room
JHRS Corner
8.30-10.30DIAGNOSIS AND TREATMENT OF IDIOPATHIC vENTRICULAR ARRHYTHMIAS Chairmen: K. Hirao / Tokyo, Japan - R. Mantovan / Cesena, Italy
Idiopathic VPC: Distribution of foci and tips of ablationY. Yamauchi / Tokyo, Japan
J wave syndrome: clinical diagnosis, risk stratification and treatmentM. Takagi / Osaka, Japan
Idiopathic ventricular tachycardia: trans-catheter ablation or anti arrhythmic drugs?C. Tondo / Milan, Italy
Electrical storm: incidence, prognosis and therapyA. Sagone / Milan, Italy
Arrhythmogenic right ventricular dysplasia / cardiomyopathy
11.00-13.00ARvD/C: FROM GENE TO THERAPY
Chairmen: G. Thiene / Padua, Italy - C. Wolpert / Ludwigsburg, Germany
Is ARVD/C still the correct name?C. Basso / Padua, Italy On genotype-phenotype correlationR.N.W. Hauer / Utrecht, The Netherlands Who needs pharmacologic therapy?D. Corrado / Padua, Italy
Who needs catheter ablation, and which approach?F.E. Marchlinski / Philadelphia, USA Who needs ICD or combined therapy?H. Calkins / Baltimore, USA
47 Advance Program
Monday 28 afternoon - Carnelutti Room
Sorin Group Luncheon Panel
13.00-14.30CRTGOALSANDISSUES:THEEXPERTS’POINTOFVIEW
Chairmen: J.C. Deharo / Marseille, France - J. Steffel / Zürich, Switzerland
CRT therapy: towards a multidisciplinary approachM. Zecchin / Trieste, Italy
Maximizing CRT efficacyB. Schaer / Basel, Switzerland
Exercise plus CRT benefitsG. Perego / Milan, Italy
CRT Health Economics: from HTA to the real approachM. Piacenti / Pisa, Italy
48
Monday 28 afternoon - Carnelutti Room
Japanese Corner
14.30-16.30REvISIT OF BRUGADA SYNDROME: FROM BASIC MECHANISM TO CATHETER ABLATION
Chairmen: P. Delise / Conegliano Veneto, Italy - H. Nakagawa / Oklahoma City, USA
Genetic mutation N. Makita / Nagasaki, Japan
Basic mechanism: repolarization abnormalitiesC. Napolitano / Pavia, Italy
Basic mechanism: RV fibrosis and conduction delayM.G. Hoogendijk / Nieuwegein, The Netherlands
Antiarrhythmic medications and ICD therapy K. Kusano / Osaka, Japan
Catheter ablation C. Tondo / Milan, Italy
SOLAECE Corner 1
17.00-19.00ABLATION OF vENTRICULAR COMPLEX SUBSTRATES
Chairmen: L. Aguinaga / Tucuman, Argentina - M. Figueiredo / Sao Paulo, Brazil
Usefulness of new imaging techniques to identify complex arrhythmogenic substrates in the ventricleG. Rodriguez Diez / Mexico City, Mexico
The challenge of ablation of substrates in the outflow tract of the right ventricle and left ventricleL. Aguinaga / Tucuman, Argentina
The challenge of ablation of ventricular arrhythmias in chagasic patients R. Keegan / Bahia Blanca, Argentina
Ventricular tachycardia ablation in ischemic heart disease: current statusW. Reyes Caorsi / Montevideo, Uruguay
49 Advance Program
APHRS Corner
8.30-10.30RvOT TACHYCARDIA: BENIGN TACHYCARDIA OR EARLY STAGE ARvD/C TACHYCARDIA?
Chairmen: G. Hindricks / Leipzig, Germany - K. Okumura / Hirosaki, Japan
Understanding the anatomy of RV and RVOTR. De Ponti / Varese, Italy
Cellular electrophysiology and ionic current of RVOTH. Honjo / Nagoya, Japan
Delayed enhanced cardiac MR image in idiopathic RVOT-VT and early stage ARVD/CK. Shivkumar / Los Angeles, USA
ICD therapy in RVOT-VT and early stage ARVD/CT.Z. Chao / Taipei, Taiwan
Catheter ablation strategy in RVOT-VT and early stage ARVD/CC. Carbucicchio / Milan, Italy
SOLAECE Corner 2
11.00-13.00RIGHT vENTRICULAR OUTFLOW TRACT TACHYCARDIAS
Chairmen: L. Molina / Mexico City, Mexico - J.L. Ramos / Rosario, Argentina
Which is the appropriate arrhythmia burden to offer RF ablation for RVOT tachycardias?C. Karmelic / Santiago, Chile
What is the real rate of cure for RVOT tachycardias?A. Fuenmayor / Mérida, Venezuela
Is balloon technique (ARRAY) better than other ablation techniques?L.C. Saenz Morales / Bogotà, Colombia
How to identify & treat epicardial origin of RVOT tachycardiasM. Scanavacca / Sao Paulo, Brazil
Tuesday 29 morning - Carnelutti Room
50
Non-invasive evaluation of arrhythmias14.30-16.30NON INvASIvE RISK MARKERS OF ARRHYTHMIC DEATH
Chairmen: N.E. El-Sherif / New York, USA - M.T. La Rovere / Montescano, Italy
Electrophysiological basis of risk markers of arrhythmic deathN.E. El-Sherif / New York, USA
Clinical risk markers of arrhythmic deathW. Zareba / Rochester, USA
ECG-derived risk markers of arrhythmic deathG. Turitto / New York, USA
Cardiovascular MRI and risk markers of arrhythmic deathM.J. Garcia / New York, USA
Present and future of genetic marker of arrhythmic deathA.A. Wilde / Amsterdam, The Netherlands
Argentinian Corner 17.00-19.00PRIMARY CARDIOMYOPATHIES AND CHANNELOPATHIES: NEW ASPECTS IN RISK STRATIFICATION, PROGNOSIS AND TREATMENT
Chairmen: N. Galizio / Buenos Aires, Argentina - O. Oseroff / Buenos Aires, Argentina
Stress provoked (Tako-Tsubo) cardiomyopathyB. Olshansky / Iowa City, USA
Idiopathic dilated cardiomyopathyS. Mittal / New York, USA
Hypertrophic cardiomyopathy F. Cecchi / Florence, Italy
Arrhythmogenic right ventricular cardiomyopathyR.N.W. Hauer / Utrecht, The Netherlands
Left ventricular non-compactationN. Galizio / Buenos Aires, Argentina
Tuesday 29 afternoon - Carnelutti Room
51 Advance Program
52
Cenacolo Room
53 Advance Program
DetailedScientific Program
Cenacolo Room
54
Sunday 27 morning - Cenacolo Room
Anatomy of the heart for electrophysiologists 8.30-10.30ANATOMY OF THE HEART RELEvANT TO SvT AND AF
Chairmen: C. Basso / Padua, Italy - H. Calkins / Baltimore, USA
Anatomy of the atria relevant to SVT and AFS.Y. Ho / London, UK
Clinical anatomy of the RA relevant to SVTR. Mantovan / Cesena, Italy
Clinical anatomy of the LA for AFE. Bertaglia / Padua, Italy
Anatomy of the heart for electrophysiologists
10.45-12.45ANATOMY FOR RESYNCHRONIZATION THERAPY
Chairmen: R. De Ponti / Varese, Italy - S.Y. Ho / London, UK
Anatomy of the coronary veins and heart for resynchronisation C. Basso / Padua, Italy
Coronary veins: imaging assessment A. Curnis / Brescia, Italy
Clinical anatomy for RA, RV implant: tips and tricks E.I. Ovsyshcher / Beer-Sheva, Israel
55 Advance Program
Sunday 27 afternoon - Cenacolo Room
Chinese Corner
14.00-16.00RACIAL INFLUENCE ON AF SUSCEPTIBILITY
Chairmen: A.M. Gillis / Calgary, Canada - D.J. Huang / Chengdu, China
Influence of race on AF A.M. Gillis / Calgary, Canada
Genetic differences in AF susceptibilityD.C.W. Siu / Hong Kong, China
Epidemiology of AF and risk factors in Asia vs Western countries S.A. Chen / Taipei, Taiwan
Incidence of AF in different racial groups as recorded by implantable devicesC.P. Lau / Hong Kong, China
Anti-thrombotic therapy of AF: is there a difference between Chinese and Caucasians? S. Zhang / Beijing, China
HRS Corner
16.00-18.00STATE OF THE ART IN ATRIAL FIBRILLATION MANAGEMENT 2013
Chairmen: D.L. Packer / Rochester, USA - E.N. Prystowsky / Indianapolis, USA
Antiarrhythmic therapy P. Dorian / Toronto, Canada
Catheter ablation H. Calkins / Baltimore, USA
Stroke prevention S.J. Connolly / Hamilton, Canada
Quality measures in AF management A.M. Gillis / Calgary, Canada
56
Monday 28 morning - Cenacolo Room
WSA Corner
8.30-10.30ATRIAL FIBRILLATION: HETEROGENEITY OF THE OPTIMAL TREATMENT WORLDWIDE
Chairmen: A. Oto / Ankara, Turkey - M. Santini / Rome, Italy
Overview of therapeutical armamentarium: appropriate indications, advantages & disadvantagesC.P. Lau / Hong Kong, China
The optimal treatment in the well developed countriesE.N. Prystowsky / Indianapolis, USA
The optimal treatment in less developed countriesS. Zhang / Beijing, China
Heterogeneity in AF treatment worldwide: a cultural or an economical problem? P. Kirchhof / Birmingham, UK
AF clinical trials update 2013
11.00-13.00STROKE PREvENTION IN AF: PARTICULAR ISSUES
Chairmen: R. De Caterina / Chieti, Italy - M. Marquez / Mexico City, Mexico
Cardioversion + oral anticoagulationA. Capucci / Ancona, Italy
Renal dysfunction + oral anticoagulationS.H. Hohnloser / Frankfurt, Germany
Coronary disease + oral anticoagulationG. Di Pasquale / Bologna, Italy
AF ablation + oral anticoagulationS. Themistoclakis / Venice-Mestre, Italy
Risk-benefit analysis of oral anticoagulation in AFS.J. Connolly / Hamilton, Canada
57 Advance Program
Bayer Luncheon Panel
13.00-14.30STROKE PREvENTION IN ATRIAL FIBRILLATION: THE ROLE OF RIvAROXABAN
Chairmen: P. Kirchhof / Birmingham, UK - A. Raviele / Venice-Mestre, Italy
Rivaroxaban in AF: not only Rocket study R. Cappato / San Donato Milanese, Italy
Use of Rivaroxaban in the real world compared to results in clinical trials: is there any difference? H. Bonnemeier / Kiel, Germany
Practical issues on the use of RivaroxabanS. Themistoclakis / Venice-Mestre, Italy
Monday 28 afternoon - Cenacolo Room
58
Monday 28 afternoon - Cenacolo Room
AF clinical trials update 2013
14.30-16.30AF REGISTRIES
Chairmen: S.J. Connolly / Hamilton, Canada - S.H. Hohnloser / Frankfurt, Germany
Overview of different registries G.Y.H. Lip / Birmingham, UK
Update on RECORDAF registryA.J. Camm / London, UK
Global burden of AF (RE-LY Registry)J. Healey / Hamilton, Canada
Newly diagnosed AF at risk of stroke (GARFIELD Registry)A. Kakkar / London, UK
Registry on LAA occlusion deviceM. Mansour / Boston, USA
AF clinical trials update 2013
17.00-19.00AF THERAPY TRIALS
Chairmen: C. Blömstrom-Lundqvist / Stockholm, Sweden - P. Dorian / Toronto, Canada
Dronedarone meta-analysisS.H. Hohnloser / Frankfurt, Germany
PALLAS sub-analysisN.S. Peters / London, UK
First-line ablation trialsC.A. Morillo / Hamilton, Canada
Ablation trials on mortality outcomeD.L. Packer / Rochester, USA
Update on LAA device and surgery trialsE. Saad / Rio de Janeiro, Brazil
59 Advance Program
Tuesday 29 morning - Cenacolo Room
Cardiac Arrhythmias Surgery8.30-10.30CONCOMITANT AF SURGICAL ABLATION
Chairmen: R.J. Jr. Damiano / St. Louis, USA - L. Salvador / Vicenza, Italy
Surgical ablation of AF: is PV electrical isolation a must?R. Codecasa / Florence, Italy
Results with bipolar RF ablation R.J. Jr. Damiano / St. Louis, USA
Results with cryoablation techniqueA. venturini / Venice-Mestre, Italy
Evaluation of results with echocardiography: the surgical point of view G. Zoffoli / Venice-Mestre, Italy
Concomitant AF surgical ablation: state of the art S. Benussi / Milan, Italy
Cardiac Arrhythmias Surgery11.00-13.00LONE AF SURGICAL ABLATION
Chairmen: U. Livi / Udine, Italy - E. Polesel / Treviso, Italy Lone AF: is there a rationale? F. Musumeci / Rome, Italy
Lone AF: Venice experience after five yearsD. Mangino / Venice-Mestre, Italy
Minimally invasive full Maze for lone AF: on pump is better?R.J. Jr. Damiano / St. Louis, USA
The “hybrid” procedureM. La Meir / Maastricht, The Netherlands
The results are better than trans-catheter approachJ.R. Edgerton / Dallas, USA
60
Tuesday 29 afternoon - Cenacolo Room
Cardiac Arrhythmias Surgery
14.30-16.30CARDIAC ARRHYTHMIAS IN PATIENTS CANDIDATE TO SURGERY: CONTROvERSIAL ISSUES
Chairmen: D. Mangino / Venice-Mestre, Italy - A. Revishvili / Moscow, Russia
Sustained ventricular arrhythmias in ischemic heart disease: surgical revascularization or ICD?C. Antona / Milan, Italy
Patients with VT and left ventricular aneurysm: what to do?L. Menicanti / San Donato Milanese, Italy
Moderate mitral valve insufficiency and AF: a good reason to anticipate operation?J.R. Edgerton / Dallas, USA
Minimal invasive mitral surgery: is it possible a complete surgical ablation?L. Salvador / Vicenza, Italy
Introduction.Left atrial appendage: surgical technique of closureD. Mangino / Venice-Mestre, Italy
Patients with AF and contraindications to oral anticoagulation: the role of minimal access surgical closure of the left atrial appendageJ.R. Edgerton / Dallas, USA
61 Advance Program
Tuesday 29 afternoon - Cenacolo Room
Russian Corner
17.00-19.00ABLATION, SURGERY AND HYBRID APPROACHES FOR TREATMENT OF LONG-STANDING PERSISTENT ATRIAL FIBRILLATION
Chairmen: A. Ardashev / Moscow, Russia - A. Revishvili / Moscow, Russia
Role of GP ablation in AF therapyH. Nakagawa / Oklahoma City, USA
Cryo - RF or “cut and sew” technique for surgical treatment of long-standing AF and concomitant heart disease?A. Revishvili / Moscow, Russia
Thoracoscopic and hybrid technology for long-standing AF ablation - indications and resultsM. La Meir / Maastricht, The Netherlands
Hybrid approach for radical treatment of long-standing persistent AFA. Curnis / Brescia, Italy
Comparison of the catheter ablation vs. rate-control strategy in patients with long-standing persistent atrial fibrillation: results of six years of follow-up A. Ardashev / Moscow, Russia
62
63 Advance Program
DetailedScientific Program
Piccolo Teatro Room
64
Sunday 27 morning - Piccolo Teatro Room
Sport and Arrhythmias 8.30-10.30NOvEL DIAGNOSTIC EXAMINATIONS IN THE EvALUATION OF ATHLETES AT RISK OF SUDDEN DEATH
Chairmen: A. Pelliccia / Rome, Italy - J. Tfelt-Hansen / Copenhagen, Denmark
Cardiac MRIM.S. Maron / Boston, USA
Cardiac CT scanF. Cademartiri / Monastier, Italy
Implantable loop recorderF. Giada / Noale, Italy
EP study and electro-anatomical mappingD. Corrado / Padua, Italy
Sport and Arrhythmias 10.45-12.45ECG SCREENING AND DETECTION OF CARDIAC DISEASE
Chairmen: D. Corrado / Padua, Italy - F. Giada / Noale, Italy
Preparticipation ECG screening: solution to the “false positive dilemma”S. Sharma / London, UK
Preparticipation ECG screening: but what about false negatives? M.S. Maron / Boston, USA
Is sudden death really epidemic? The great U.S. vs Italy debate on ECG screening, including societal considerationsPRO: A. Pelliccia / Rome, Italy CON: B.J. Maron / Minneapolis, USA
Does detecting cardiac disease with ECG screening save/prolong life?D. Corrado / Padua, Italy
To screen or not to screen. That is the question J. Tfelt-Hansen / Copenhagen, Denmark
65 Advance Program
Sunday 27 afternoon - Piccolo Teatro Room
Sport and Arrhythmias
14.00-16.00DIFFICULTCASES:LET’SDISCUSSTOGETHER
Chairmen: P. Delise / Conegliano Veneto, Italy - S. Sharma / London, UK
Gene positive-phenotype negative for HCM and eligibility for sports: U.S. vs Italy againB.J. Maron / Minneapolis, USA
Negative T wave in the lateral leads with no evidence of hypertrophyF. Cecchi / Florence, Italy
Athletes with J-wave ECG patternA.D. Krahn / Vancouver, Canada
Athlete with asymptomatic AFL. Mont / Barcelona, Spain
Athlete with complete left bundle branch blockP. Delise / Conegliano Veneto, Italy
Sport and Arrhythmias
16.00-18.00HOT TOPICS AND CONTROvERSIES IN ARRHYTHMIAS & SPORTS
Chairmen: L. Calò / Rome, Italy - N.E. El-Sherif / New York, USA
How common are athletic field deaths really? Emotion vs dataB.J. Maron / Minneapolis, Italy
How do you make disqualification decisions when there are no data at all? LV noncompactionP. Zeppilli / Rome, Italy
Patients with minor forms of cardiomyopathy/channelopathies can perform leisure sports activitiesPRO: A. Biffi / Rome, Italy CON: S. Sharma / London, UK
AED must be mandatory in all sports events and sports facilitiesPRO: M. Santomauro / Naples, Italy CON: B. Olshansky / Iowa City, USA
66
Monday 28 morning - Piccolo Teatro Room
New technologies and techniques for catheter ablation
8.30-10.30MAPPING,IMAGING,ABLATING:WHAT’SNEW?
Chairmen: F.E. Marchlinski / Philadelphia, USA - S. Themistoclakis / Venice-Mestre, Italy
Non invasive ECG mapping to guide catheter ablation P. Jaïs / Bordeaux, France
FIRM mapping: real progress or just increment?S.M. Narayan / San Diego, USA
New imaging technologies to characterize arrhythmic substrateA. Dello Russo / Milan, Italy
Technologies for better lesion creation W.G. Stevenson / Boston, USA
Technologies for measuring catheter contactJ. Kautzner / Prague, Czech Republic
Value of ICE for the electrophysiologists
11.00-13.00INTRACARDIAC ECHOCARDIOGRAPHY: ADvANCES IN TECHNIQUES AND APPLICATIONS
Chairmen: D. Callans / Philadelphia, USA - D.L. Packer / Rochester, USA
New windows for ICE imaging: using unconventional approachesC.F. Liu / New York, USA
Left atrial appendage morphology: are ICE and CT correlations feasible?P. Santangeli / Philadelphia, USA
ICE for left atrial appendage imaging: can it be improved? D. Lakkireddy / Kansas City, USA
ICE guided CRT: is there evidence of reverse remodeling?S. Saksena / New Brunswick, USA
Three-dimensional ICE imagingA. Al-Ahmad / Palo Alto, USA
67 Advance Program
Monday 28 afternoon - Piccolo Teatro Room
Role of Cardiac Imaging in Electrophysiology
14.30-16.30ROLE OF CARDIAC IMAGING IN ELECTROPHYSIOLOGY
Chairmen: D. Callans / Philadelphia, USA - S. Iliceto / Padua, Italy
Role of echocardiography in the evaluation and management of atrial fibrillationF. Rigo / Venice-Mestre, Italy
ICE for interventional electrophysiology A. Rossillo / Venice-Mestre, Italy
Role of cardiac imaging for the exclusion of LAA thrombiA. Dello Russo / Milan, Italy
How reliable is to assess the presence and extension of atrial fibrosis by cardiac MR imagingM. Perazzolo Marra / Padua, Italy
Role of cardiac MR imaging in the evaluation and management of patients with ventricular arrhythmiasM.J. Garcia / New York, USA
Vasovagal Syncope
17.00-19.00NEGLECTED ASPECTS OF vASOvAGAL SYNCOPE
Chairmen: A. Moya / Barcelona, Spain - R. Sutton / Monte Carlo, Monaco
The meaning of vasovagal reactions in animalsP. Alboni / Ferrara, Italy
The meaning of vasovagal syncope in humansJ.J. Blanc / Brest, France
Vasovagal syncope starting in the young and in the elderly: the same nosologic entity?W.K. Shen / Phoenix, USA
Psychological disturbances in subjects with frequent vasovagal syncope: possible cause or consequence?R.S. Sheldon / Calgary, Canada
68
Tuesday 29 morning - Piccolo Teatro Room
Syncope 2013 Update8.30-10.30Opening remarksA. Raviele / Venice-Mestre, Italy
PATHOPHYSIOLOGY OF SYNCOPE
Chairmen: D.G. Benditt / Minneapolis, USA - B. Olshansky / Iowa City, USA
Cerebral autoregulation in health and disease: role in syncopeJ.G. van Dijk / Leiden, The Netherlands
The evolutionary origins of vasovagal syncopeP. Alboni / Ferrara, Italy
Susceptibility to vasovagal syncope: inhereted or acquired?R.S. Sheldon / Calgary, Canada
Idiopathic paroxysmal AV block: what is the mechanism?M. Brignole / Lavagna, Italy
Case study # 1J.J. Blanc / Brest, France
Syncope 2013 Update11.00-13.00CLINICAL EvALUATION AND RISK STRATIFICATION
Chairmen: F. Giada / Noale, Italy - S. Mittal / New York, USA
Long-term impact of recurrent syncope on cerebral function and quality of lifeC.A. Morillo / Hamilton, Canada
Conditions mimicking syncope: recognition and managementR. Sutton / Monte Carlo, Monaco
Risk stratification of the syncope/collapse patientW.K. Shen / Phoenix, USA
How to set up a syncope unitR.A. Kenny / Dublin, Ireland
Case study #2A. Bartoletti / Florence, Italy
69 Advance Program
Tuesday 29 afternoon - Piccolo Teatro Room
Syncope 2013 Update14.30-16.30DIAGNOSTIC INvESTIGATION OF SPECIFIC CONDITIONS
Chairmen: L. Aguinaga / Tucuman, Argentina - M. Santini / Rome, Italy
Marked bradycardia in asymptomatic athlete: when should we worry?D.G. Benditt / Minneapolis, USACarotid sinus syndrome: its history, mechanisms and prevalenceR.A. Kenny / Dublin, IrelandPhysiology and clinical manifestations of orthostatic hypotensionA. Gonzalez-Hermosillo / Mexico City, MexicoThe ‘soft’ autonomic dysfunction syndromes (POTS, IST): what are they? Does any treatment work?B. Olshansky / Iowa City, USACase study #3A. Ungar / Florence, Italy
Syncope 2013 Update17.00-19.00SYNCOPE: DILEMMAS
Chairmen: M. Brignole / Lavagna, Italy - C.A. Morillo / Hamilton, Canada
Is tilt-table testing dead? Can it predict which vasovagal syncope patients will benefit from pacing?A. Moya / Barcelona, Spain The ATP controversy: does ATP really have a role in evaluation of older syncope patients?A.D. Krahn / Vancouver, CanadaCardio-neuroablation for vasovagal syncope: placebo effect or effective therapy? M. Scanavacca / Sao Paulo, Brazil Syncope in the systolic and the diastolic heart failure patient: iatrogenic and cardiac issues and managementL.W. Stevenson / Boston, USACase study #4D. Hachul / Sao Paulo, Brazil Closing remarksD.G. Benditt / Minneapolis, USA - B. Olshansky / Iowa City, USA
7070
71 Advance Program70
DetailedScientific Program
Cipressi Room
72
Sunday 27 morning - Cipressi Room
Sudden Cardiac Death, ICD and Surroundings8.30-10.30REDUCING SCD AROUND THE WORLD: PROBLEMS AND POTENTIAL SOLUTIONS
Chairmen: G. Breithardt / Münster, Germany - E.N. Prystowsky / Indianapolis, USA
AsiaC.P. Lau / Hong Kong, China
EuropeG. Breithardt / Münster, Germany
South AmericaM. Marquez / Mexico City, Mexico
North AmericaD.S. Cannom / Los Angeles, USA
Maximizing available resourcesE.N. Prystowsky / Indianapolis, USA
Sudden Cardiac Death, ICD and Surroundings10.45-12.45ICD: TECHNICAL, CLINICAL & ETHICAL ASPECTS
Chairmen: H. Klein / Rochester, USA - J.M. Morgan / Southampton, UK
ICD implantation after acute myocardial infarction: postpone for 4 weeks or “wait and see”? G. Steinbeck / Munich, Germany
The ICD in the environment of MRI: recent developmentsC.G. Wollmann / St. Pölten, Austria
The ICD at the end of life of the patient: in whom and when to switch off?G.L. Botto / Como, Italy
The wearable cardioverter defibrillator: where and does it fit in our practice?TBD
Sudden unexpected death surrounding epilepsy (SUDEP): mechanisms and preventionR.N.W. Hauer / Utrecht, The Netherlands
73 Advance Program
Sunday 27 afternoon - Cipressi Room
ISHNE Corner
14.00-16.00REDUCING INAPPROPRIATE ICD THERAPY IN LIGHT OF MADIT-RIT AND ADvANCE III
Chairmen: D.S. Cannom / Los Angeles, USA - L. Padeletti / Florence, Italy
Clinical significance of inappropriate ICD therapiesA. Proclemer / Udine, ItalyMADIT-RIT: results of the randomized trial W. Zareba / Rochester, USAOptimal programming of ICDsH. Klein / Rochester, USAAdvance III: results of the randomized trialM. Gasparini / Rozzano, ItalyRole of ATP in reducing inappropriate shocksM. Lunati / Milan, ItalyRole of remote device monitoring in reducing inappropriate shocksS. Dubner / Buenos Aires, Argentina
Remote monitoring of cardiac arrhythmias / device
16.00-18.00REMOTE MONITORING: TECHNICAL, PRACTICAL, ECONOMIC ISSUES
Chairman: J.S. Steinberg / New York, USA - B.L. Wilkoff / Cleveland, USA
Integrating the healthcare enterprise: IHE and connecting heart rhythm informationD.J. Slotwiner / New York, USAKey EP data elements: role in data interchange, quality, outcomes & patient careB. Jennings / Kalamazoo, USAWhat is the impact of remote monitoring on health care resource consumption? A cost / benefit analysisR.P. Ricci / Rome, ItalyPractical implementation of a remote monitoring networkM. Santini / Rome, ItalyCoping effectively and efficiently with monitoring dataJ.S. Steinberg / New York, USA
74
Monday 28 morning - Cipressi Room
EHRA Corner8.30-10.30OPTIMAL THERAPY IN PATIENTS WITH HEART FAILURE
Chairmen: L. Mont / Barcelona, Spain - J.M. Morgan / Southampton, UK
What is best medical therapy in patients with systolic and diastolic heart failure? L.W. Stevenson / Boston, USAOptimal device therapy in CHF-patients with a wide QRS: how important is MRI compatibilityC. Wolpert / Ludwigsburg, GermanyTherapy in CHF-patients with a narrow QRS: combination of subcutaneous defibrillators with CCM devices? M. Borggrefe / Mannheim, GermanyDoes home monitoring improve outcome in CHF-patients? J.M. Morgan / Southampton, UKEHRA EP-wires surveys: what is common practice in pacemaker lead management?C. Blomström-Lundqvist / Uppsala, Sweden
St. Jude Medical Satellite Symposium11.00 - 13.00 FLUOROSCOPY EXPOSURE DURING ABLATION PROCEDURES AND DEvICE IMPLANTATION: REDUCING THE RISK FOR PATIENTS AND CLINICIANS
Chairmen: L. Calò / Rome, Italy - P. Jaïs / Bordeaux, France
Risks related to fluoroscopy radiation associated with electrophysiology proceduresE. Picano / Pisa, ItalyNear-zero fluoroscopic exposure during catheter ablation of supraventricular arrhythmias: the Italian experience of the NO PARTY trialM. Casella / Milan, ItalyRoutine implant of biventricular ICD guided by an electroanatomic mapping systemM. Del Greco / Trento, ItalyCatheter ablation of atrial fibrillation without radiation exposure using a 3D mapping systemM. Scaglione / Asti, ItalyThe unique MediGuide technology for CRT lead placement and catheter ablationC. Pappone / Cotignola, ItalyRole of Mediguide in AF/SVT/VT ablation – The LESSRADS Registry D. Lakkireddy / Kansas City, USA
75 Advance Program
Medtronic Emerging leaders Luncheon Panel
13.00-14.30EMERGING LEADERS IN ELECTROPHYSIOLOGY: CASE PRESENTATION AND DISCUSSION
Chairman: E.N. Prystowsky / Indianapolis, USA
Faculty: M.R. Gold / Charleston, USA S.H. Hohnloser / Frankfurt, Germany M. Santini / Rome, Italy
Monday 28 afternoon - Cipressi Room
76
Monday 28 afternoon - Cipressi Room
Heart failure and resynchronization therapy14.30-16.30INDIvIDUALIZING CARDIAC RESYNCHRONIZATION THERAPY DELIvERY (1)
Chairmen: M.R. Gold / Charleston, USA - J.S. Steinberg / New York, USA CRT in patients with right bundle branch block: yes, no, perhaps?M.R. Gold / Charleston, USA
Role of PVC ablation in improving the response rate of CRT patientsD. Lakkireddy / Kansas City, USA Persistent and permanent AF in CRT patients: which treatment strategy?M. Brignole / Lavagna, Italy Targeted LV lead placement to guide CRT: a worthy approach?P. Lambiase / London, UK Radiation dose reduction during CRT implantation: do we have an issue here?A.M. Russo / Cherry Hill, USA
Heart failure and resynchronization therapy17.00-19.00INDIvIDUALIZING CARDIAC RESYNCHRONIZATION THERAPY DELIvERY (2)
Chairmen: J.C. Daubert / Rennes, France - C. Linde / Stockholm, Sweden AV optimization in CRT: when is it useful?M.R. Gold / Charleston, USA
Follow-up of a CRT patient: when remote, when in-personJ.C. Daubert / Rennes, France
CRT super-responder: worth thinking to downgrade from CRT-D to CRT-P?C. Linde / Stockholm, Sweden
Percutaneous mitral valve repair in CRT patients: indication and outcomeK.H. Kuck / Hamburg, Germany
Lead extraction in CRT patients: frequency, challenges, and outcomeC. Kennergren / Gothenburg, Sweden
77 Advance Program
Tuesday 29 morning - Cipressi Room
Indian Corner
8.30-10.30CRT: ELECTROCARDIOGRAPHY, PATIENT SELECTION AND OPTIMAL APPLICATION IN EMERGING NATIONS
Chairmen: D. Lakkireddy / Kansas City, USA - S. Saksena / New Brunswick, USA
ECG patterns in CRT A. Ravikishore / Bangalore, India Optimizing CRT - do we need more baseline dataK.K. Sethi / New Delhi, India
Optimizing CRT - do we need more imaging methodsA.E. Epstein / Philadelphia, USA
Optimizing CRT - do we need more leads and delivery methods B.L. Wilkoff / Cleveland, USA CRT in AF and heart failureJ. Brachmann / Coburg, Germany
CRT: pre-implant, implant & post-implant issues
11.00-13.00OPTIMIZATION OF CRT THERAPY Chairmen: C. Linde / Stockholm, Sweden - K.K. Sethi / New Delhi, India
Refining candidates for CRT therapy beyond current guidelines: ECG and imaging toolsR. ventura / Bremen, Germany
Co-morbidities and CRT: when should they modify patient selection?P. Santangeli / Philadelphia, USA
Pre-implant assessment for optimal LV lead placement: ECG, echo or MRI?M.R. Gold / Charleston, USA
Intraoperative imaging for CRT optimization: is there a role?S. Saksena / New Brunswick, USA
Postoperative optimization: is its role diminishing? M. Lunati / Milan, Italy
78
Tuesday 29 afternoon - Cipressi Room
Contemporary and controversial issues in cardiac pacing
14.30-16.30TECHNOLOGICAL ISSUES
Chairmen: E.I. Ovsyshcher / Beer-Sheva, Israel - F. Zanon / Rovigo, Italy
Automatic features of pacemakers: how important are they?O. Oseroff / Buenos Aires, Argentina
The future of sensors for rate adaptive pacingA. Oto / Ankara, Turkey
Total remote follow-up in pacemekers clinic: pearls and pittfallsR.P. Ricci / Rome, Italy
Leadless pacing: where are we?L. Padeletti / Florence, Italy
Biological pacemakers: will they be the future?W. Jung / Villingen, Germany
Contemporary and controversial issues in cardiac pacing
17.00-19.00CLINICAL ISSUES
Chairmen: E. Occhetta / Novara, Italy - A.M. Russo / Cherry Hill, USA
Pacemaker therapy in vasovagal syncope: when, why and how?R. Sutton / Montecarlo, Monaco
After DANPACE II, should AAI pacing be considered obsolete?P.E. Bloch-Thomsen / Hellerup, Denmark
How important is minimization of RV pacing?J.C. Daubert / Rennes, France
Alternate sites for RV pacing: always or only in selected cases?E.I. Ovsyshcher / Beer-Sheva, Israel
How to use pacemaker logs to manage patients with AF?G.L. Botto / Como, Italy
79 Advance Program
80
Cipressi Room
81 Advance Program
DetailedScientific Program
Barbantini Room
82
Sunday 27 morning - Barbantini Room
Lead extraction and device infection
8.30-10.30CLINICAL LEAD MANAGEMENT ISSUES
Chairmen: M.G. Bongiorni / Pisa, Italy - C. Kennergren / Gothenburg, Sweden
What are the treatment options for patients with CIED infection?C. Love / Columbus, USA
What are the implantation options for patients with occluded veins?T. Blum / Bad Krozingen, Germany
What are the treatment options for patients with recalled leads?J.C. Deharo / Marseille, France
What are the treatment options for young patients with superfluous functional and non-functional leads?C. Kennergren / Gothenburg, Sweden
Lead extraction and device infection
10.45-12.45LEAD EXTRACTION: A EUROPEAN PERSPECTIvE
Chairmen: C. Blomström-Lundqvist / Uppsala, Sweden - J.C. Deharo / Marseille, France
Indications for lead extraction (case-based)M. Taborsky / Olomouc, Czech Republic
Results and risks in lead extraction: does the extraction volume matter?G. Pelargonio / Rome, Italy
The current status of lead extraction in EuropeM.G. Bongiorni / Pisa, Italy
Safety and training requirements in lead extractionP. Mitkowski / Poznan, Poland
83 Advance Program
Sunday 27 afternoon - Barbantini Room
Mexican Corner
12.45-14.00THE USE OF ANTICOAGULANTS IN MEXICO
Chairmen: L. Molina / Mexico City, Mexico - N. Reyes / Puebla, Mexico
Thromboembolism working groups in Mexico (LICET): current status and future perspectivesN. Reyes / Puebla, Mexico
The role of new anticoagulants before AF ablationM. Marquez / Mexico City, Mexico
Anticoagulant treatment after AF ablation: when, how and whyA. Majiluf / Mexico City, Mexico
“Ablate and pace”: which indications for new anticoagulants?L. Molina / Mexico City, Mexico
New methods of AF mappingM. Haïssaguerre / Bordeaux, France
84
Sunday 27 afternoon - Barbantini Room
HRS Corner
14.00-16.00CIED LEAD MANAGEMENT STRATEGIES
Chairmen: A.M. Russo / Cherry Hill, USA - B.L. Wilkoff / Cleveland, USA
RIATA, Fidelis & the next Safety alertC. Love / Columbus, USA
ESRD patients: risks, benefits and alternatives for SCD R.L. Page / Madison, USA
Venous access & alternative strategiesS.P. Kutalek / Philadelphia, USA
Infection prevention & novel treatment strategiesB.L. Wilkoff / Cleveland, USA
German Corner 16.00-18.00NOvEL PACING STRATEGIES
Chairmen: G. Steinbeck / Munich, Germany - C. Wolpert / Ludwigsburg, Germany
Intracardiac vagal stimulation - clinical applicationP. Schauerte / Berlin, Germany
Vagal stimulation in heart failure: which results and perspectives?M. Borggrefe / Mannheim, Germany
Defibrillation without intracardiac leads: a real progress?J. Winter / Düsseldorf, Germany
Cardiac contractility modulation - where do we go?K.H. Kuck / Hamburg, Germany
The future of pacing W. Jung / Villingen, Germany
85 Advance Program
Monday 28 morning - Barbantini Room
CHRS Corner
8.30-10.30CONTROvERSIES IN CATHETER ABLATION AND EP TRAINING
Chairmen: P. Guerra / Montreal, Canada - A. verma / Toronto, Canada
Improvements in AF ablation outcome will be based more on technological advancement versus mechanistic understandingPRO: C.A. Morillo / Hamilton, CanadaCON: S. Willems / Hamburg, Germany
We are underutilizing VT ablation in patients with ischemic cardiomyopathyPRO: A.D’Avila / New York, USACON: J.L. Sapp / Halifax, Canada
European / Canadian round-table on EP training harmonizationCanadian perspective: P. Guerra / Montreal, CanadaEuropean perspective: J.L. Merino / Madrid, Spain
Pediatric aspects of cardiac arrhythmias
11.00-13.00MANAGEMENT OF CARDIAC ARRHYTHMIAS IN PEDIATRIC AGE
Chairmen: G. Kudaiberdieva / Bishkek, Kyrgyzstan - M.J. Strieper / Atlanta, USA
Unusual pediatric anatomy and challengesE. Saarel / Salt Lake City, USA Clinical use and limitations of non-invasive EP testsG. Kudaiberdieva / Bishkek, Kyrgyzstan Non-flouroscopic EP studies in the pediatric labJ. Clark / Akron, USA Cryo vs radiofrequency ablation for AVNRTJ. Kirsch / Toronto, Canada
Difficulties in pacemaker and ICD implantationA. Kiliç / Ankara, Turkey
86
Monday 28 afternoon - Barbantini Room
Arrhythmias in adults with congenital heart disease: beyond evidence-based medicine
14.30-16.30MECHANISMS AND PREvENTION OF ARRHYTHMIAS
Chairmen: J. Hebe / Bremen, Germany - E. Rosenthal / London, UK
Anatomy: view to the morphology of the unoperated heart S.Y. Ho / London, UK
Arrhythmogenesis: incidence and substrates for tachycardia: where to burn (or not) in 2020?N.A. Blom / Leiden, The Netherlands
Prognosticators in a heterogeneous population: objectives for primary prevention?E. Rosenthal / London, UK
Resynchronisation of the “abnormal” heart - who is a candidate - on what rationale?H. Abdul-Khaliq / Homburg-Saar, Germany
Arrhythmias in adults with congenital heart disease: beyond evidence-based medicine
17.00-19.00THERAPEUTIC CHALLENGES
Chairmen: N.A. Blom / Leiden, The Netherlands - R. ventura / Bremen, Germany
Anatomy: view to the morphology of the operated heartS.Y. Ho / London, UK
Atrial tachycardia: lessons learned from 20 years of interventional treatmentJ. Hebe / Bremen, Germany
Ventricular tachycardia: systematic approaches despite variant anatomy K. Zeppenfeld / Leiden, The Netherlands
Challenges of device implantation: any limitations left in 2013?F. Drago / Rome, Italy
87 Advance Program
Tuesday 29 morning - Barbantini Room
ECAS Corner8.30-10.30LATEST NEWS IN THE EvALUATION AND MANAGEMENT OF CARDIAC ARRHYTHMIAS Chairmen: R. Cappato / San Donato Milanese, Italy - D. Shah / Geneva, Switzerland
New mapping tools for cardiac arrhythmiasJ. Sra / Milwaukee, USA
Cryptogenic stroke and role of loop recorderJ. Brachmann / Coburg, Germany
Exercise-induced ARVC: fact or fiction?H. Heidbüchel / Leuven, Belgium
Experimental evidence of the role of renal sympathetic denervation for treating atrial fibrillationJ.S. Steinberg / New York, USA
Post-operative atrial fibrillation: what’s new in management?M. Imazio / Turin, Italy
88
Tuesday 29 afternoon - Barbantini Room
Brazilian Corner14.30-16.30EPICARDIAL ACCESS FOR vT ABLATION: HOW IT CAN HELP SOLvING COMPLEX PROBLEMS. AN INTERACTIvE CASE-BASED APPROACH
Chairmen: E. Saad / Rio de Janeiro, Brazil - M. Scanavacca / Sao Paulo, Brazil Pericardial access - how to get it and avoid complicationsK. Shivkumar / Los Angeles, USA Ablation in the pericardial space - how to deal with fat, coronaries, phrenic nerves and lack of blood flowA.D’Avila / New York, USA Unipolar voltage maps to predict epicardial substrates - pearls and pitfallsD. Callans / Philadelphia, USA
Upfront epicardial access for every VT ablation case - risks and benefitsW.G. Stevenson / Boston, USA The future lies in the epicardium - what we can expect and how to get thereP. Jaïs / Bordeaux, France
Middle East Corner17.00-19.00PECULIAR ISSUES IN THE MANAGEMENT OF CARDIAC ARRHYTHMIAS IN MIDDLE EAST
Chairmen: A.M. Al Musaad / Riyadh, KSA - C. Jazra / Beirut, Lebanon
Atrial fibrillation management: lessons from the Middle East registriesA.A. Alsheikh-Ali / Abu Dhabi, UAE
Strength and weakness in implementing atrial fibrillation ablation program in the regionM. Khoury / Beirut, Lebanon
Primary indication for ICD: can we reduce the cost/benefit ratio?M. Shenasa / San José, USA
Long term follow-up of implanted devices in the regionR. Sweidan / Jiddah, KSA
89 Advance Program
90
91 Advance Program
DetailedScientific Program
Consiglio Room
92
Sunday 27 morning - Consiglio Room
Allied Professionals Program
8.30-10.30Opening Remarks: S. Damiani / Venice-Mestre, Italy - B. Thomas / Austin, USA
INSIGHTS INTO THE MANAGEMENT OF COMPLEX ARRHYTHMIAS IN THE EP LAB
Chairmen: S. Damiani / Venice-Mestre, Italy - B. Thomas / Austin, USA
Mapping and ablation of PVC (case study)M. Brown / Austin, USA How to monitor a patient during AF ablationG.M. Francese / Catania, ItalyThe allied professional role during epicardial ablationC. Monreal / Austin, USA Conscious sedation, deep sedation or general anesthesia during ablation: advantages & disadvantagesL. Cappellesso / Venice-Mestre, ItalyManagement of acute complications in the EP labA. De Conto / Conegliano Veneto, Italy
Allied Professionals Program
10.45-12.45HOT TOPICS IN 2013
Chairmen: S. Beheiry / San Francisco, USA - L. Morichelli / Rome, Italy
Oral anticoagulation therapy: a new paradigmA. Ferrick / New York, USAEmerging technologies in the EP labP. China / Venice-Mestre, ItalyImproving the patient experience pre and post EP procedureM. Lane / Austin, USAOptimal programming of ICD for shock reductionK. Zedlitz / Austin, USACRT therapy: what’s new?J. Copeland / Akron, USA
93 Advance Program
Sunday 27 afternoon - Consiglio Room
Allied Professionals Program14.00-16.00ATRIAL FIBRILLATION TODAY
Chairmen: L. Plebani / Novara, Italy - K. Zedlitz / Austin, USA
Selecting the appropriate patients for AF ablationS. Lovison / Venice-Mestre, Italy
Intracardiac electrograms: what are the doctors looking at when they do AF ablations? C. Cronin / Austin, USA
How to improve patient results of RF ablation in long-standing persistent AFP. Santangeli / Philadelphia, USA
Post-ablation monitoring for success: what type and how much is enough?C. Teckenbrock / Austin, USA
AF Consensus DocumentS. Beheiry / San Francisco, USA
Closing Remarks: A. Natale / Austin, USA - A. Raviele / Venice-Mestre, Italy
Association of Patients Program16.00-18.00HOW TO IMPROvE THE MANAGEMENT OF CARDIAC ARRHYTHMIAS: ROLE OF ADvOCACY AND PATIENT EDUCATION
Chairmen: A.J. Camm / London, UK - T. Lobban / Stratford-upon-Avon, UK
Improving patient outcomes, what else can be done?T. Lobban / Stratford-upon-Avon, UK
What should a doctor tell a patient with arrhythmias?J. Jerrome / Stratford-upon-Avon, UK
Education, medication or devices in the treatment of reflex syncope?R. Sutton / Monte Carlo, Monaco
AF: am I at risk? What should I do?M. Madalosso / Venice-Mestre, Italy
Is there a role for advocacy in arrhythmia care?N. Gadhok / London, UK
94
Monday 28 morning - Consiglio Room
French Corner8.30-10.30DAILY CHALLENGES IN ASYMPTOMATIC PATIENTS: FROM CASE REPORTS TO GUIDELINES
Chairmen: E. Aliot / Vandoeuvre-lès-Nancy, France - J.J. Blanc / Brest, France
A patient with an asymptomatic hypertrophic cardiomyopathyB.J. Maron / Minneapolis, USAAn asymptomatic patient with low ejection fraction and a wide left bundle branch blockJ.C. Daubert / Rennes, FranceA patient with an asymptomatic atrial fibrillationG. Hindricks / Leipzig, GermanyA patient with asymptomatic cerebral lesions during AF ablationE.G. vester / Düsseldorf, GermanyA patient with an asymptomatic early repolarizationF. Sacher / Bordeaux, France
Medico Satellite Symposium10.45-13.00CAN HAEMODYNAMIC SENSING IMPROvE THE PACING THERAPY IN THE REMOTE MONITORING ERA?
Chairmen: P. Mabò / Rennes, France - L. Padeletti / Florence, Italy
Haemodynamic alterations induced by cardiac pacing: is clinical evaluation sufficient or do we need long-term device monitoring?E. Aliot / Vandoeuvre-lès-Nancy, FranceCan Trans Valvular Impedance detect changes in the mechanical performance of the heart?F.R. Dorticòs Balea / La Havana, CubaTachyarrhythmias in pacemaker patients: what to ask to the device diagnostics?A.M. Gillis / Calgary, CanadaWhat are the benefits of matched TVI and intracardiac ECG recording in discriminating between supraventricular and ventricular tachyarrhythmias?C. Pandozi / Rome, Italy
Celebrating 40 years of Medico SpA
95 Advance Program
Monday 28 afternoon - Consiglio Room
Mechanisms and ablation of cardiac arrhythmias
14.30-16.30MECHANISMS & vALUE OF EP STUDY
Chairmen: M.M. Scheinman / San Francisco, USA - K. Soejima / Kawasaki, Japan
Mechanisms of cardiac arrhythmias F.E. Marchlinski / Philadelphia, USA
Mechanisms and treatment options for patients with genetic arrhythmic syndromesM.J. Ackerman / Rochester, USA
Role of the autonomics in the pathogenesis of atrial fibrillation C. Pappone / Cotignola, Italy
Use of the EP laboratory to diagnose patients with SVT M.M. Scheinman / San Francisco, USA Use of the EP laboratory to diagnose patients with wide complex tachycardia H. Calkins / Baltimore, USA
Mechanisms and ablation of cardiac arrhythmias
17.00-19.00ABLATION OF CARDIAC ARRHYTHMIAS
Chairmen: M.M. Scheinman / San Francisco, USA - G. Turitto / New York, USA
Ablation of AVNRT and junctional tachycardias M.M. Scheinman / San Francisco, USA
Ablation of typical and variant accessory pathways F.E. Marchlinski / Philadelphia, USA
Ablation of atrial fibrillation M. Haïssaguerre / Bordeaux, France
Ablation of idiopathic VT E. Aliot / Vandoeuvre-lès-Nancy, France
Ablation of VT associated with structural cardiac disease K. Soejima / Kawasaki, Japan
96
Tuesday 29 morning - Consiglio Room
Present your most challenging cases - Rising stars and more8.30-10.30SUPRAvENTRICULAR ARRHYTHMIASChairmen: A. Rossillo / Venice-Mestre, Italy - M.M. Scheinman / San Francisco, USA
A difficult case of SVT Presenter: R. verlato / Camposampiero, ItalyDiscussant: H. Nakagawa / Oklahoma City, USAA difficult case of atrial tachycardiaPresenter: J.D. Burkhardt / Austin, USADiscussant: M.M. Scheinman / San Francisco, USAA difficult case of right atrial flutterPresenter: G.B. Chierchia / Brussels, Belgium Discussant: F. Gaita / Turin, ItalyA difficult case of left atrial flutterPresenter: L. Mont / Barcelona, SpainDiscussant: M. Hocini / Bordeaux, FranceA difficult case of AFPresenter: T. Gaspar / Dresden, GermanyDiscussant: A. verma / Montreal, Canada
Present your most challenging cases - Rising stars and more11.00-13.00vENTRICULAR ARRHYTHMIASChairmen: L. Di Biase / New York, USA - W.G. Stevenson / Boston, USA
A difficult case of VA in a patient with myocarditis: ICD yes/no after ablationPresenter: M. Tritto / Castellanza, ItalyDiscussant: W.G. Stevenson / Boston, USAA difficult case of VA in non ischemic cardiomyopathyPresenter: C. Carbucicchio / Milan, Italy Discussant: K. Zeppenfeld / Leiden, The NetherlandsA difficult case of VA in ischemic cardiomyopathyPresenter: R. De Ponti / Varese, ItalyDiscussant: A.D’Avila / New York, USAA difficult case of epicardial ablationPresenter: E. Saad / Rio de Janeiro, BrazilDiscussant: K. Shivkumar / Los Angeles, USAA questionable indication for ICD extraction after successful ablationPresenter: J.C. Deharo / Marseille, FranceDiscussant: D.S. Cannom / Los Angeles, USA
97 Advance Program
Arrhythmias in the elderly
14.30-16.30PRACTICAL ISSUES: A CASE-BASED APPROACH
Chairmen: A.E. Epstein / Philadelphia, USA - W.K. Shen / Phoenix, USA
Case 1My 86 year-old frail lady with atrial fibrillation. Also has hypertension, diabetes, and creatinine of 2: would you recommend anticoagulation? Which agent? What is the role of LA appendage occlusion?C. Jazra / Beirut, LebanonDiscussants: G. Barbato / Bologna, Italy; A.E. Epstein / Philadelphia, USA; T. Lewalter / Munich, Germany; T. Potpara / Belgrade, Serbia
Case 2My 86 year-old patient with dilated cardiomyopathy, NYHA II, EF 30%. Also has hypertension, COPD, degenerative joint disease, claudication, creatinine 2.5. Referred to you for ICD: what would you recommend?S. Nisam / Bierges, BelgiumDiscussants: G. Boriani / Bologna, Italy; G.L. Botto / Como, Italy; D.S. Cannom / Los Angeles, USA; C. Linde / Stockholm, Sweden
Case 3My 86 year-old patient with recurrent syncope. Also has hypertension, CAD, stable angina, Parkinson’s, on multiple drugs. Take us through the evaluationJ.J. Blanc / Brest, FranceDiscussants: M. Brignole / Lavagna, Italy; F. Giada / Noale, Italy; R.S. Sheldon / Calgary, Canada; W.K. Shen / Rochester, USA
Case 4My 86 year-old patient wants ICD off after repeated shocks. Also has CAD, prior MI, EF 15%, NYHA III, diabetes, sleep apnea; he is pacemaker dependent. What would you recommend?L.R. Scott / Phoenix, USADiscussants: J.C. Deharo / Marseille, France; A.M. Gillis / Calgary, Canada; E. Occhetta / Novara, Italy
Tuesday 29 afternoon - Consiglio Room
98
Consiglio Room
99 Advance Program
DetailedScientific Program
Borges Room
100
Polish Corner
10.45-12.45INNOvATIvE APPROACHES IN DEvICE MANAGEMENT
Chairmen: J.K. Wranicz / Lodz, Poland - W. Zareba / Rochester, USA
Optimal selection of patients for CRT-DW. Zareba / Rochester, USA
Triple-site CRTR. Lenarczyk / Zabrze, Poland
New methods of monitoring patients with devicesJ.K. Wranicz / Lodz, Poland
Role of medications in reducing inappropriate therapyS. Dubner / Buenos Aires, Argentina
Innovative approaches in lead extractions A. Kutarski / Lublin, Poland
Sunday 27 morning - Borges Room
101 Advance Program
Sunday 27 afternoon - Borges Room
Persian Corner
14.00-16.00AF TREATMENT IN IRAN: CONTEMPORARY ISSUES
Chairmen: M. Eslami / Tehran, Iran - M. Shenasa / San José, USA
Recent advances in the molecular pathophysiology of AFR. Wakili / Munich, Germany
Management of AF in rheumatic heart disease: drugs, ablation, surgeryM. Eslami / Tehran, Iran
Atrial fibrillation ablation in elderly in IranZ. Emkanjoo / Tehran, Iran
Multimodality navigation: how far can we go? A. Arya / Tehran, Iran
SOLAECE Corner 2
16.00-18.00MAXIMIZING USE OF TECHNOLOGY
Chairmen: L. Molina / Mexico City, Mexico - M. Scanavacca / Sao Paulo, Brazil
3-D mapping & radiofrequency ablation without “x” rays: why, when and howE. Saad / Rio de Janeiro, Brazil
Usefulness of rotational image reconstruction immediately before pulmonary vein isolation & for other ablation strategiesW. Uribe / Medellin, Colombia
Implantable loop recorder before pulmonary vein isolation as best tool for diagnosis and long term follow-upE. Sternick / Belo Horizonte, Brazil
Use of intracardiac echocardiography for ablation of right ventricular outflow tract tachycardiasW. Uribe / Medellin, Colombia
102
Monday 28 morning - Borges Room
Asymptomatic AF8.30-10.30SILENT AF: DETECTION, PROGNOSIS AND INTERvENTIONS Chairmen: H. Kottkamp / Zurich, Switzerland - A. Raviele / Venice-Mestre, Italy Epidemiologic and prognostic implications of “silent” AFA. Capucci / Ancona, ItalyDevice based detection: approaches and validationT. Lewalter / Munich, GermanyStroke and silent AF: a critical assessmentR. Hatala / Bratislava, Slovak RepublicClinical trials in silent AF: are they essential for AF interventions? W. Jung / Villingen, GermanyImplications of silent AF and its progression for AF clinical trialsS. Saksena / New Brunswick, USA
Modern management of AF11.00-13.00IMPROvING THE CONTINUUM OF CARE IN PATIENTS WITH AF: HOW CAN WE MAKE IT SYSTEMATIC?
Chairmen: P. Dorian / Toronto, Canada - T. Lobban / London, UK
International perspective on outcomes in atrial fibrillation in the emergency room - details from the RELY-AF RegistryJ. Healey / Hamilton, CanadaDesign and implementation of a systematic approach to patients presenting with atrial fibrillation in the emergency room: the Innovate-AF projectP. Dorian / Toronto, Canada The benefits of a systematic, nurse clinician lead atrial fibrillation programJ.M.L. Hendriks / Maastricht, The Netherlands Panel discussion P. Dorian / Toronto, Canada J. Healey / Hamilton, CanadaJ.M.L Hendriks / Maastricht, The NetherlandsT. Lobban / London, UKC. Morais / Lisbon, PortugalA. Rossillo / Venice-Mestre, Italy
103 Advance Program
Monday 28 afternoon - Borges Room
EHRA Corner
14.30-16.30TRANSLATIONAL APPROACHES IN PERSISTENT ATRIAL FIBRILLATION
Chairmen: A. Goette / Magdeburg, Germany - J.L. Merino / Madrid, Spain
Differences in quality of life in paroxysmal and persistent AFK.H. Ladwig / Munich, Germany
Novel concepts and tools for catheter ablation of persistent AFG. Hindricks / Leipzig, Germany
Pathophysiological characterizations of fractionated electrograms: how to define ablation targets? D. Lau / Maastricht, The Netherlands
Long-term outcome after ablation of persistent AFF. Gaita / Turin, Italy
Indian Corner
17.00-19.00THE LEFT ATRIAL APPENDAGE: NEW INSIGHTS & INTERvENTIONS
Chairmen: S. Saksena / New Brunswick, USA - K.K. Sethi / New Delhi, India Imaging the left atrial appendage: techniques and advancesB. Singh / Gurgaon, India
Does the anatomy of left atrial appendage correlate with the risk of stroke?A. Natale / Austin, USA
Mapping the left atrial appendage during AF ablationC. Tondo / Milan, Italy
Percutaneous device occlusion of the left atrial appendage: current statusT. Lewalter / Munich, Germany Catheter ablation of AF in combination with left atrial appendage closure: feasibility and resultsL. Boersma / Nieuwegein, The Netherlands
104
Tuesday 29 morning - Borges Room
Portuguese Corner
8.30-10.30AF ABLATION: PORTUGUESE EXPERIENCE
Chairmen: P. Adragão / Carnaxide, Portugal - C. Morais / Lisbon, Portugal
Indications for AF ablation: before or after AA drugs failure?J. Primo / Lisbon, Portugal
Mapping AF P. Carmo / Carnaxide, Portugal
PV isolation: one-shot ablation?J. De Sousa / Lisbon, Portugal
Robotic AF ablationD. Cavaco / Carnaxide, Portugal
How to follow AF ablation patients?M.M. Oliveira / Lisbon, Portugal
Spanish Corner11.00-13.00 “HOT EP TOPICS” IN SPAIN IN 2013: ECONOMY, CLINICAL RESULTS, ACCREDITATION & ORGANIZATION
Chairmen: J.L. Merino / Madrid, Spain - L. Mont / Barcelona, Spain
ICD implantation practice within Europe: how to explain the differences beyond economy?I. Fernandez-Lozano / Madrid, Spain
Results from ablation registries in Europe: a gap between publications and clinical practice? J.L. Merino / Madrid, Spain
Spanish multicentre trials on AF ablation: new answers for old questionsL. Mont / Barcelona, Spain
Outcomes and consequences after 10 years of a national accreditation program on EPJ.L. Merino / Madrid, Spain
How to develop a leading national scientific society in EP? Processes and keys for successA. Moya / Barcelona, Spain
105 Advance Program
106
Borges Room
107 Advance Program
Scientific InformationGeneral Information
Registration InformationHotel Information
Practical Information
108
Scientific Information
SCIENTIFIC SECRETARIATAntonio Raviele, MD, FESC, FHRSCardiologist and ArrhythmologistFormer Director of the Cardiovascular DepartmentDell’Angelo HospitalPresident of the Alliance to Fight Atrial Fibrillation (ALFA)Phone +39 041 5322788 - Fax +39 041 5329484 E-mail: [email protected]
ABSTRACT GUIDELINES AND ONLINE SUBMISSIONAbstract must be submitted electronically only via the Abstract Submission System available at www.venicearrhythmias.org
Abstracts submitted after the deadline might not be accepted.For all the information for the abstract submission, please check the websitewww.venicearrhythmias.org/abstract_submission/
QUESTIONSIf you have any questions about submitting an abstract, please [email protected]
ACCEPTANCENotification of Acceptance/Non-acceptance: announcements will be e-mailed by June 16th 2013.
REGISTRATION OF ABSTRACT PRESENTERSAbstract presenters are required to register for the Scientific Sessions by June 30th 2013.Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter. The person inserted in the online form as “Presenting Author” will be considered the presenter. If the registration is not accomplished within the scheduled time, the abstract will not be inserted in the Abstract Book published by JAFib.
SLIDESOnly PC data projection will be available in every room. All slides must be worded only in English; please copy your work - prepared in Power Point - on a CD or USB pen. The Speaker Ready Room will be available for presenters and speakers to preview their slides and to become familiar with the audiovisual equipment. The use of personal laptops in the Workshop rooms is not allowed.
POSTERSAll posters must be prepared with dimension “portrait” 70cm width x 100cm height. Specific instructions about mantling, display and dismantling will be e-mailed in due time.
ALLIED PROFESSIONALS SESSIONSThree sessions on clinical and managing aspects of nursing in arrhythmology will be held on October 27 2013 in Italian or English language.
OFFICIAL LANGUAGEThe official language of the congress is ENGLISH. No translations will be provided during the scientific session except for the Allied Professionals Program.
Program Chairs
109 Advance Program
Scientific Information
Special EventsOPENING CEREMONYSunday October 27, 2013 - included in the registration feeThe Workshop will be inaugurated by the Congress Presidents, by Representatives of the Italian and International Scientific Societies and Study Groups that have granted their patronage, by the City Mayor and other Authorities.
GEOGRAPHIC AREAS SPECIAL BEST ABSTRACT AWARDSSunday October 27, 2013VeniceArrhythmias 2013, following the great success of the last edition, will give six special awards in Euros - for the “Best Communication” according to the presenter’s area of origin (Asia, Eastern Europe, Latin America, Middle East, Northern America, Western Europe). There will be an Abstract Award Committee that will select the best works among accepted oral communications and posters. The winners will be announced during the Opening Ceremony.
RAFFAELLA PIERI BREAKTHROUGH COMMUNICATION AWARDSunday October 27, 2013In memory of Mrs. Raffaella Pieri, whose oustanding, years-long contribution in managing the relations with VeniceArrhythmias’ exhibitors and supporting companies, on behalf of the meeting’s Organizing Secretariat, and as well as in regard to her ever-helpful approach and highly missed sensibility, VA 2013 Organizing Committee has decided to create the “Raffaella Pieri Breakthrough Communication Award”, to be given to the most cutting-edge communication message presented by VA 2013 exhibitors, in terms of strength, efficacy and innovative power.The winner will be awarded with a plaque, and with a charitable donation to a primary cancer research foundation, made on his/her behalf.
110
General Information
ORGANIZING SECRETARIATADRIA CONGREX SrlVia Sassonia, 30 - 47922 Rimini - ItalyPh. +39 0541 305822 - Fax +39 0541 305842
E-mails: general information: [email protected] information: [email protected] & exhibition: [email protected] & housing: [email protected]
www.venicearrhythmias.org
During the Workshop the Organizing Secretariat will be at your disposal at theFondazione Giorgio Cini.
CONGRESS vENUEFONDAZIONE GIORGIO CINIIsola San Giorgio Maggiore - 30124 Venice - ItalyPhone +39 041 5289900 - Fax +39 041 5238540www.cini.it
Program Chairs
111 Advance Program
HOW TO REACH THE CONGRESS vENUE FONDAZIONE GIORGIO CINIIsola San Giorgio Maggiore - 30124 Venice – ItalyPhone +39 041 5289900 - Fax +39 041 5238540www.cini.it
From Marco Polo Airport of veniceBy water:• a water taxi costs about Euro 90,00/100,00• a motor boat which takes you from the airport via Murano Island and Lido toPiazza San Marco costs about Euro 25,00/30,00
By land:• from San Marco “San Zaccaria” waterbus no. 2• a taxi which costs about Euro 30,00 and takes you to Piazzale Roma• a public water bus (no. 52 or no. 2) from Piazzale Roma to San Giogio Islandcosts Euro 7,00 per way, alternatively a water taxi costs about Euro 60,00/70,00
From venice Santa Lucia Railway StationBy water:• a water taxi which costs about Euro 60,00/70,00• a water bus no. 2 via the Giudecca Channel costs Euro 7,00 per way – if viaCanal Grande a supplement of Euro 2,00 is requested
By land:• please follow signs for Piazza San Marco and take the waterbus no. 2
From A4 Motorway venice Exit• park at Tronchetto, waterbus no. 2
Congress Venue
San Marco
Congress Venue
I S O L A D I S . G I O R G I O M A G G I O R E
C A N A L E D E L L A G I U D E C C A
CA
NA
L G R A N D E
C A N A L G R A N D E
Tronchetto
Marco Polo
Airport
PA
RK
IN
G
Piazzale Roma
Venice Lido
Santa LuciaRailway Station
N T E D E L L A L I B E R TA’
112
SAvE UP TO 20% ON TRAvEL WITH THE STAR ALLIANCE™ NETWORK
The Star Alliance member airlines are pleased to be appointed as the Official Airline Network for vENICE ARRHYTHMIAS 2013.
To obtain the Star Alliance Conventions Plus discounts please follow the below steps to access the Conventions Plus online booking tool: • Visit www.staralliance.com/conventionsplus/delegates/ • Under “Delegates login” enter conventions code LH70S13.• The online booking tool opens in a separate window**Should the online booking tool not open, please ensure that your Pop-Up blocker is disabled.
Registered participants plus one accompanying person travelling to the event can qualify for a discount of up to 20%, depending on fare and class of travel booked.
The participating airlines for this event are: Adria Airways, Aegean Airlines, Air Canada, Air China, Air New Zealand, ANA, Asiana Airlines, Austrian Airlines, AviancaTaca, Brussels Airlines, Copa Airlines, Croatia Airlines, EgyptAir, Ethiopian Airlines, LOT Polish Airlines, Lufthansa, Scandinavian Airlines, Singapore Airlines, South African Airways, SWISS International Air Lines, TAP Portugal, THAI, Turkish Airlines, United, US Airways.
Discounts are offered on most published business and economy class fares, excluding website/internet fares, senior and youth fares, group fares and Round the World fares.
Please note: For travel to/from Japan and New Zealand special fares or discounts may be offered by the participating airlines on their own network. To obtain these special fares or discounts and for booking office information please visit www.staralliance.com/conventionsplus/delegates/ and: • Click on “Conventions Plus Booking Contacts” and enter the conventions code
LH70S13.• Choose one of the participating airlines listed• Call the respective reservation contact listed and quote the conventions code
LH70S13 when requesting the special ticket
When making your travel plans please present confirmation of your registration or proof of attendance for the Event/Convention.
Transport Information
Program Chairs
113 Advance Program
Registration Information
REGISTRATION FEES
Before May 31, 2013From June 1 up to
October 9, 2013From
October 10, 2013
Delegates € 950,00 € 1.050,00 € 1.100,00
Accompanying Persons € 250,00 € 300,00 € 370,00
Exhibitors € 425,00 € 475,00 € 525,00
Allied Professionals € 95,00 € 95,00 € 120,00
All fees includes Italian VAT (actually 21%)
Registration fee for Delegates and Presenters includes:• Attendance to all scientific sessions (limited to seats availability)• Entrance to the exhibition area• Attendance certificate • Badge and congress kit Registration fee for Accompanying Persons includes:• Entrance to the exhibition area • Half-day excursion
Registration fee for Exhibitors includes:• Entrance to the exhibition area • Badge and congress kit
The registration fee for Allied Professionals includes:• Attendance to scientific sessions (limited to Allied Professionals sessions) • Entrance to the exhibition area • Attendance certificate • Badge and congress kit
For any information please contact [email protected]
GROUP PRE-REGISTRATIONIf you wish to register a group of more than 10 people, please contact the Organizing Secretariat at [email protected]
114
Registration & Hotel Information
HOTEL ACCOMMODATIONAs October is considered peak tourist season in Venice, it is recommended to book in great advance and possibly within May 31, 2013.
The Organizing Secretariat will make all efforts to confirm your reservation in the hotel category of your choice; if not possible, an alternative proposal will be submitted for your approval. Venetian hotels have very few single rooms, therefore double room for single occupancy (DSO) will be assigned once the single rooms are no longer available. The majority of the hotels pre-booked for VeniceArrhythmias are located in Venice, once they are fully booked, alternative hotels located in Venice Lido or Mestre might be assigned.Confirmation documents will be sent starting from July 31, 2013.Please note that hotels are listed per categories/rate ranges and rooms will be assigned according to availability on a “first-come, first-served” basis.
PAYMENT TERMSPayments accepted are: credit cards, cheques written on Italian Banks and Bank Transfer in Euro.
All costs to transmitters’ charge. Please indicate clearly your name and VeniceArrhythmias 2013 on cheque/money orders; a copy of the payment is requested together with the registration and hotel accommodation forms.Registration and Hotel Accommodation will be confirmed only on receipt of the relevant payments. The settlement is required to process your reservation. Adria Congrex will issue a regular invoice for registration (21% VAT inclusive) and hotel accommodation (10% VAT inclusive); therefore the European VAT code (only for EU countries) is due to be included in the forms.Please note that VAT could be subject to changes. The VAT rate will be applied depending on the Italian fiscal law at the time of payment.
Program Chairs
115 Advance Program
Registration & Hotel Information
CANCELLATION TERMS Any cancellation should be notified in writing to Adria Congrex and will be subject to the following conditions:
Before August 31, 2013 Refund of the registration and hotel accommodation is subject to a 30% administrative charges. All refunds, if any, will be made after the congress (all costs to receivers’ charge).
After September 1, 2013 No refund of any kind.
CHANGES IN PROGRAM For scientific and/or technical reasons the Scientific Committee, the Organizing Committee and the Secretariat reserve the right to make any change in the Workshop program.
116
Venice Hotel List
5-STAR HOTEL Single Room/DSU Double room24 BAUER 575,0030 DANIELI 435,00 485,0036 HILTON 365,00 400,004-STAR HOTEL Single Room/DSU Double room27 AL PONTE DEI SOSPIRI 350,00 350,0026 ALL’ANGELO 380,00 380,00F AUSONIA & HUNGARIA (*) 154,00 165,00D BIASUTTI (*) 195,0012 CA ALVISE 350,00 350,0032 CA DEI CONTI 310,00 330,004 CA’ NIGRA 415,0017 CA PISANI 425,00 450,006 CARLTON 350,003 CARNIVAL PALACE 350,0019 CENTURION PALACE 385,00 385,0028 DONA 380,00 380,0018 DRAGOMANNI 350,0022 DUODO PALACE 350,00 350,00G EXCELSIOR (*) 190,00 220,0035 GABRIELLI 300,00 360,0016 LA FENICE 275,00 330,00H LE BOULEVARD (*) 250,00 350,0034 LOCANDA VIVALDI 310 /420 310 /42033 LONDRA PALACE 380,00 / 500,00 380,00 / 500,0025 MONACO GRAND CANAL 490,00 500,001 NH LAGUNA PALACE (**) 125,00 145,007 PALAZZO GIOVANNELLI 410,00 440,0010 PALAZZO SANT’ANGELO 319,00 319,00B PANORAMA VENEZIA (*) 200,00 210,005 PAPADOPOLI 410,00 410,00I PETIT PALAIS (*) 110,00 120,00E QUATTRO FONTANE (*) 190,009 RUZZINI PALACE 350,00 350,008 SANTA MARINA 350,00 350,0011 SPLENDID SUISSE 410,00 410,00A VIKTORIA PALACE HOTEL (*) 155,00 165,00L VILLA LAGUNA (*) 190,00C VILLA MABAPA (*) 190,00M VILLA PANNONIA (*) 0,00 200,003-STAR HOTEL Single Room/DSU Double room2 ATENEO 300,0013 CANALETTO 300,0023 CASANOVA 240,00 255,0031 CASA VERARDO 300,0015 CENTAURO 300,0020 DELL’OPERA 300,0029 LUX 170,00 / 215,00 200,00 / 270,0014 SAN GIORGIO 300,00 300,0022 SAN MOISE 300,00 300,00N VILLA EDERA 130,00 145,00(*) Located in Venice-Lido(**) Located in Venice-Mestre
Program Chairs
117 Advance Program
Hotel Map
FON
DA
ZIO
NE
GIO
RGIO
CIN
I
San
Mar
co S
quar
e
Casin
ò
Rialt
o Br
idge
Gall
erie
dell’
Acc
adem
iaS.
Mar
iade
lla S
alute
Chur
ch7
8
27
1
2021 23
24
9 1012
14
19
Cana
l Gra
nde
Cana
l Gra
nde
Cana
l Gra
nde
Giud
ecca
2
5 6
2615
28
4
22
VEN
ICE
B
C
D
VEN
ICE
LID
O
29
VEN
ICE
MES
TR
E
3
11 13
30
17
16
18
FG
H
25
31
32
33
34
35
E
A
IL
MN
36
118
Practical Information
HOW TO ARRIvE IN vENICEPlease visit www.venicearrhythmias.org for practical and tourists information about Venice.
vISA/INTERNATIONAL ATTENDEE INFORMATIONIn addition to a passport, most international participants will need a Visa. It is advisable to contact the Italian Embassy or Consulate regarding Visa and Health Certificate requirements in your country of residence. The Organizing Secretariat is available to send you a Letter of Invitation for Visa Purposes. The invitation is meant to help participants obtaining a Visa, and is not a commitment on the part of the organizers to provide any financial support. The decision to grant a Visa belongs to the Embassy/Consulate.
CLIMATE AND CLOTHINGVenice has a mild and moderate climate. The weather in October might be pleasant during the day, a little bit colder at night. Formal clothing/attire is requested at the Workshop sessions.
ELECTRICITYElectricity supplied is 220V/50Hz and power sockets are of different types.
NO-SMOKING POLICYVeniceArrhythmias 2013 is a NO SMOKING workshop; therefore, smoking is not allowed in the meeting rooms, exhibition spaces and restrooms. Smoking is permitted in the outdoor spaces. Your compliance is appreciated.
SAFETY RECOMMENDATIONSVenice is as safe as any other European cities and delegates are advised to take the usual sensible precautions. All hotels have security facilities for valuables.
Program Chairs
119 Advance Program
Practical Information
120
Program Chairs
121 Advance Program
The Organizing Committeewishes to express its gratitude to the following Companies
for the support to the Workshop(Updated on September 2013)
CMYK
BICROMIA
A partner for people. For life.
122
Important Dates
October 10, 2013Deadline for discounted registration fees
Mark Your Agenda!
Program Chairs
123 Advance Program
Organizing SecretariatAdria Congrexwww. [email protected]
corners
AWARDS
preSenTa
Tion
S
LiVe lectures
SympoSia
FeaTU
reD